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Current understanding of Blastocystis pathogenicity and of host-parasite 
interactions is incomplete. In working towards uncovering mechanisms 
underlying Blastocystis spp. infection, effects of the parasite on various 
elements of host immunity were investigated with in vitro approaches in this 
study. 
 
Isolates of Blastocystis spp. subtypes 7 and 4, ST7-B and ST4-WR1 
respectively, were studied in terms of differences in cellular size and 
intracellular protein content. A centrifugation-based methodology was 
optimised to separate small and large parasites. Separated fractions of small 
and large parasites were used in subsequent exposure experiments with 
MoDCs. CFSE labelling of live ST7-B and ST4-WR1 parasites was also 
optimised for confocal microscopy with MoDCs. Blastocystis effects on TLR-
mediated NF-κB activation were studied using THP1-Blue, a transgenic 
human monocytic cell line with a reporter SEAP gene function. Quantitative 
real time-PCR was used to assess gene expression. TEER measurement was 
used to assess permeability across host cell monolayers. MoDC functional 
phenotypes were investigated using surface marker analysis by flow 
cytometry, ELISA, confocal microscopy and lymphocyte proliferation assays.  
 
We found that for similar number of parasites, protein content of ST7-B 
parasite lysate was found to contain approximately 5-fold higher protein 
content than that of ST4-WR1. Data from THP1-Blue experiments suggested 
that both live Blastocystis spp. and parasite lysate failed to induce NF-κB 
viii 
 
activation. ST7-B, but not ST4-WR1 was able to augment LPS-mediated NF-
κB activation. A dose-dependent inhibition in ZG-mediated NF-κB activation 
was observed for both ST4-WR1 and ST7-B. Both ST7-B and ST4-WR1 
showed no modulating effect on Fla-mediated NF-κB activation. In TEER 
measurements, we not only confirmed Blastocystis-mediated increase in 
epithelial permeability but also showed that at similar exposure ratios of Caco-
2 cells to parasites, only ST7-B induced significant increase in epithelial 
permeability. However, we observed a similar increase in permeability of 
Caco-2 exposed to ST4-WR1 at exposure ratios adjusted to match those of 
ST7-B by protein content. In MoDC studies, we observed MoDC activation 
and maturation only via direct contact to live ST7-B, by significant up-
regulation in CD80 and CD83 expression and TNF-α production. We also 
observed that live ST7-B mediated significant augmentation in LPS-induced 
MoDC activation and maturation. Using size-segregated populations of live 
parasites, we observed that both small and large cell populations of only ST7-
B induced significant MoDC maturation by CD83 up-regulation. Through 
confocal microscopy with live CFSE-labelled parasites, we observed uptake of 
Blastocystis by MoDCs. 
 
We conclude that Blastocystis effects on host tissue may be different due to 
varying parasite size and protein content and varying parasite burden in 
infections. Findings from TLR studies may reflect perturbations to PAMP-
TLR signalling along gut mucosa during a Blastocystis infection, contributing 
to disruptions to immune homeostasis and gut inflammatory state. We also 
conclude that there may be differing degrees of immunogenicity between 
ix 
 
isolates of different subtypes, possibly dysregulating adaptive responses and 
contributing to onset of immunopathologies associated with Blastocystis, such 
as urticaria.    
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1.1 BLASTOCYSTIS SPP. TAXONOMY, BIOLOGY AND 
PHYSIOLOGY 
Blastocystis spp. is an enteric and anaerobic eukaryotic protistan parasite that 
has been isolated from the large intestines of hosts that span a wide species 
range including humans
1,2
. Blastocystis spp. was first described in the early 
1900s and is now grouped taxonomically under the stramenopiles, a varied 
range of heterotrophic and photosynthesis protists that includes algae, diatoms, 
slime moulds and oomycetes
3
, and interestingly is the only known member to 
infect humans and be associated with human pathology
4
. In addition, due to 
the low species specificity and the highly zoonotic nature exhibited by 
numerous isolates of the parasite, previous species-allocation conventions 
have become less accepted and the parasite is now collectively classified 
under the species complex Blastocystis spp. Identifying nomenclature of the 
parasite has been consolidated into a system of consensus terminology
5
, which 
classifies all known Blastocystis spp. isolates into subtypes based on sequence 
similarities in small-subunit ribosomal RNA. To date, 17 subtypes have been 





Blastocystis spp. is observed to occur in 4 different cell morphologies, the 
vacuolar, granular, amoeboid and cyst forms, with the vacuolar form being 
most commonly observed
7
. The vacuolar form has a surface coat of varying 
thickness that is carbohydrate-rich and is proposed to play a role in trapping 
and degrading bacteria for nutrition
7,8
.  Amoeboid forms of the parasite were 
3 
 





, and have since been observed by others
11–13
. Granular 
forms of the parasite are structurally similar to the vacuolar form, except for 
the presence of numerous distinct granules in the central body of the parasite, 
suggested to be metabolic and lipid storage granules through electron 
microscopic studies
3
. The cyst form is widely accepted to be the transmissible 
form via the faecal-oral route. There is no consensus on the detailed life cycle 
of Blastocystis spp,, although at a basic level, binary fission, plasmotomy and 
budding have been observed in in vitro cultures of isolates from faecal 
samples
11
. Various studies have demonstrated in vitro induction of encystation 
and excystation of the parasite from and to non-cyst forms respectively
14,15
. 
Generated cysts were used to infect some animal models in early in vivo 
studies
16,17
. However, these encystation protocols have not been applied to all 
subtypes and so it is as yet unknown if the encystation process would be 
present in all Blastocystis spp. subtypes. Others have called into question the 
encystation method as the morphology of the in vitro induced cysts do not 




1.2 BLASTOCYSTIS SPP. PREVALENCE AND EPIDEMIOLOGY 
Blastocystis spp. has a global distribution and several epidemiological 
investigations on parasite prevalence from human faecal samples report it as 
the most common eukaryotic parasite
4,19
. Prevalence follows a trend of 
developing countries generally having a higher prevalence rate than 
industrialised countries due to the former having lower sanitation standards, 
4 
 
increased interactions with other host species and subsequent contamination of 
food and water sources
4
. Such associations are consistent with the faecal-oral 
route of transmission of the parasite. There is high variation in prevalence of 
Blastocystis spp. among nations, from 0.5-1% in an industrialised country like 
Japan
20
 to as high as 60% in Indonesia
21
. Intra-country variation has also been 
documented for Blastocystis prevalence, for examples in Thailand, from 0.9% 
to 45.2%
22,23




However, much of the variation of prevalence depends on the method of 
detection used, the sensitivity of which may differ among the various 
techniques, and the subpopulation sampled
4,25
. Almost all epidemiological 
studies conducted report that Blastocystis spp. subtype 3 is most commonly 
detected, with exceptions of higher frequency of detection of subtype 4 in 
some parts of Western Europe, and of subtype 1 in Thailand
4
. Other 
prevalence studies in a wide range of geographic locations support the 
observation that subtype 3 predominates in human infections, followed by 
subtype 1 and that other subtypes, namely 2, 4, 6, 7, 8, and 9, in decreasing 
frequency
25
. Variations in severity of symptoms associated with Blastocystis 
spp. has been attributed to its immense genetic diversity, although no clear 
associations have been elucidated between clinical symptoms and Blastocystis 
subtypes
4
. For instance, subtype 3 has been isolated from both asymptomatic 
and symptomatic individuals
7
; while studies have reported both the presence 
of subtype 4 in symptomatic populations and the isolation of subtype 4 





1.3 BLASTOCYSTIS SPP. STATUS OF PATHOGENICITY 
Infections with Blastocystis spp. are usually associated with gastrointestinal 
symptoms such as diarrhoea, abdominal pain, flatulence, nausea, vomiting and 
weight loss
4,25
, although a large proportion of people who harbour the parasite, 
especially isolates of subtype 2
27
, stay asymptomatic. Symptomatic carriage of 
the parasite is termed as blastocystosis
7
. Immunocompromised individuals, 
especially human immunodeficiency virus infection/acquired 
immunodeficiency syndrome (HIV/AIDS) patients, transplant recipients and 
patients in critical condition and on life support are most at risk of developing 
Blastocystis-associated symptoms, suggesting that the parasite may behave as 
an opportunistic pathogen
28,29
. Blastocystis spp. has also been implicated with 
several extra-intestinal symptoms, such as cutaneous disorders and acute or 
chronic urticaria
4,30–33
. More specifically, subtypes 2 and 3 were detected via 
PCR of faecal samples, and the amoeboid form of the parasite has been 




However, the status of Blastocystis spp. as a pathogen is still controversial as 
studies have yet to address Koch’s postulates without a suitable animal 
model
7







. It should be noted that although work 
with these animal models have contributed data supporting pathogenicity of 
Blastocystis spp., mice are not natural hosts of Blastocystis spp. and the 
animals used so far in models are hosts to subtypes that are not commonly 
detected in humans
7
. In the absence of a robust and suitable animal model to 
6 
 
study host-pathogen interactions by subtypes most commonly detected in 
humans, associations have been drawn between potential pathogenicity of 
subtypes and their prevalence among symptomatic populations
7
. However, this 
is once again dependent on the method of detection used and its sensitivity in 
accurate detect of Blastocystis and the population sampled.  
 
Irritable bowel syndrome (IBS) is defined as a functional group of bowel 
disorders in which abdominal pain is associated with defecation or alterations 
in bowel habit in the absence of an organic cause
36,37
. IBS is subtyped 
according to bowel habit pattern, namely diarrhoea-(IBS-D) or constipation-
predominant IBS (IBS-C) or an alternating subtype (IBS-A), which fluxes 
between the two states
38
. Blastocystis spp. is also increasingly associated with 
IBS, though there is no clear evidence for a causative link between 
Blastocystis spp. and IBS, or for the parasite having a major role in disease 
pathophysiology. Subtypes 1 and 3 isolates were reported to be more prevalent 





1.4 MUCOSAL IMMUNITY OF THE GUT 
1.4.1 The intestinal epithelium 
Intestinal epithelial cells (IECs) are structurally and functionally polarized, 
with an apical surface facing the intestinal lumen and a basolateral surface 





form a physical and functional barrier, separating host cells in the underlying 
submucosa from microbiota residing in the intestinal lumen and facilitating 
uptake metabolic and digestive functions
40
. Most of the cells that make up the 
colonic epithelium are absorptive enterocytes, other cell populations with roles 
in immune homeostasis include goblet cells and Paneth cells that secrete 
mucins and antimicrobial peptides into the lumen respectively
40
. Goblet cells 
also secrete trefoil factor 3 (TFF3) and resistin-like molecule-β (RELMβ). 
TFF3 provides structural integrity to mucus through mucin crosslinking and 
acts as a signal that promotes epithelial repair, migration of IECs and 
resistance to apoptosis
40. RELMβ functions to promote MUC2 secretion, 
regulate macrophage and adaptive T cell responses during inflammation and, 
in the setting of nematode infection, directly inhibit parasite chemotaxis
40
. In 
the human colon, mucus consists of 2 layers extending 400µm above the 
epithelium
41
. Using mouse models, both layers were found to have similar 
protein composition, with the large gel-forming mucin MUC2 as the major 
structural component
42
. The inner layer is densely packed, firmly attached to 
the epithelium, and devoid of bacteria, while the outer layer is movable, has an 
expanded volume due to proteolytic cleavages of the MUC2 mucin, and is 
colonized by bacteria
42
. These mucus layers form the first line of defence 
against colonization of pathogenic microbes.  
 
Antimicrobial peptides (AMPs) form another vital component of protection of 
the intestinal epithelium against microbial pathogens. IECs are capable of 
producing the C-type lectin regenerating islet-derived protein IIIγ (REGIIIγ) 
throughout the small intestine and colon, while Paneth cells are uniquely 
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adapted for the secretion of many additional AMPs, including defensins, 
cathelicidins and lysozyme, in the crypts of the small intestine
40
. These AMPs 
disrupt highly conserved, essential bacterial molecular structures, such as 
pore-forming defensins and cathelicidins which act on surface membranes, 
and C-type lectins which target Gram-positive cell wall peptidoglycans
40
. It 
has been observed that the mucus layers and AMPs work in close proximity, 
with localisation and concentration of secreted AMPs by the surface-
overlaying mucus, resulting in a combined physical and antibacterial barrier to 
prevent bacterial attachment and invasion
43
. This distribution facilitates high 
local peptide concentration on vulnerable mucosal surfaces, while still 




IECs are also known to directly transport secretory dimeric IgA complexes 
across the epithelial barrier after secretion from plasma cells in the lamina 
propria
40
. These complexes are bound by the polymeric immunoglobulin 
receptor (pIgR), expressed on the basolateral membrane of IECs and actively 
transcytosed towards the apical side of the epithelium, into the intestinal 
lumen
40,44
. These secretory IgA complexes are the first form of antigen-
specific elements of adaptive immunity in the gut mucosal milieu. 
 
1.4.2 Immune homeostasis and states of inflammation 
In addition to physical and biochemical barriers, IECs also act as frontline 
sensors for microbial encounters and to integrate detected signals into 
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antimicrobial or immunoregulatory responses, based on whether the sources of 
the signals are pathogenic or commensal in nature. IECs express several 
different classes of pathogen recognition receptors (PRRs) that detect 
conserved microbial molecular patterns. Examples of classes of such receptors 
include the Toll-like receptors (TLRs), NOD-like receptors (NLR), and the 
RIG-I-like receptor (RLR) families. The functions of these receptor classes not 
only serve the vital role of immune-surveillance against microbial pathogens, 
but also contribute towards normal gut epithelial physiology and function. Due 
to the myriad communities of non-pathogenic microbiota lining the intestinal 
epithelium, a response to molecular patterns from commensal, non-pathogenic 
microbiota would be damaging to the host
39
. Instead, the intestinal epithelium 
not only exhibits a tolerance towards the presence of such commensal-derived 
factors and does not mount an acute inflammatory immune response, but 
actually requires these signals for its normal function and for sensing a breach 
in its barrier
39
.   
 
Polarized expression of PRRs by IECs at either the apical or basolateral 
membrane may contribute to the discrimination between commensal and 
pathogen microbial signals
40
. For example, signalling through surface or 
endosomal TLR-9 at the apical pole of IECs promotes the inhibition of NF-κB 
signalling, whereas TLR signalling from the basolateral pole promotes NF-κB 
activation
40
. Subsequently, NF-κB activation mediates expression of 
cytoprotective heat-shock proteins, epidermal growth factor receptor ligands 
and TFF3, and also enhances integrity of apical tight-junction complexes
40
. In 
studies with mice knockout models, IEC-specific deletion of TLR-controlled 
10 
 
NF-κB signalling machinery was found to exacerbate both spontaneous colitis 
and dextran sodium sulphate (DSS)-induced colitis. 
 
Upon detection of pathogenic microbes and activation of receptors like TLRs, 
downstream effector responses include pro-inflammatory chemokines, 
cytokines and reactive oxygen species (ROS). Besides the microbicidal nature 
of ROS produced by IECs and immune cells either resident in the submucosa 
or recruited to the site of infection, ROS has been found to promote epithelial 
cell repair by inactivating redox-sensitive tyrosine phosphatases and 
promoting IEC-specific formation of focal adhesions, which are necessary for 




In maintaining balance between a state of hyporesponsiveness against 
commensals and the mounting of specific inflammatory responses against 
microbial pathogens, IECs exert several mechanisms of control over 
recruitment, activation and function of immune cells involved in gut mucosal 
immunity. Immune cells involved in intestinal immunity residing in the lamina 
propria directly beneath the epithelium include innate lymphoid cells (ILCs), 
B cells (especially IgA-producing plasma cells), T cells, macrophages and 
dendritic cells (DCs)
39,40
. Of the intestinal mononuclear phagocytes that are 
involved in antigen presentation, two distinct populations that have been 
















Firstly, IECs regulate the induction of both cellular and humoral adaptive 
immune responses through a continuous cross-talk with antigen-presenting 
immune cells such as DCs, the primary antigen-presenting cell to naïve T cell 
populations and the link between innate and adaptive arms of host immunity. 
IECs express thymic stromal lymphopoietin (TSLP), transforming growth 
factor-β (TGFβ) and retinoic acid (RA) in response to commensal-derived 
factors
40
. These molecular mediators promote the development of tolerogenic 
properties in DCs, such as the capability to direct the differentiation of 
forkhead box P3 (FOXP3
+) regulatory T cells via TGFβ- and RA-dependent 
mechanisms
40,49–51
. Retinoic acid produced by activated CD103
+
 DCs is also 
found to be crucial for directing naïve CD4
+
 T cells to become gut-homing, 





By producing TSLP and IL-25, IECs are also crucial in driving development 
of naive T cell differentiation towards the T helper 2 (TH2) outcome post 
antigen presentation
40,52,53
. TSLP and IL-25 promote the expansion and 
differentiation of distinct populations of basophil progenitors and multipotent 
progenitor cells, which develop mononuclear and myeloid cell phenotypes that 
promote the development of type 2 cytokine responses at mucosal sites and 
represent an innate link between IEC-derived signals and the polarization of 







1.4.3 Pathophysiology of IBS and changes to the intestinal epithelium 
Dysregulation of intestinal immune homeostasis is increasingly regarded to 
play an integral role in post-infectious IBS, which is the development of new 
IBS symptoms after an infectious event
54
. Changes in mucosal immunological 
status, such as elevations in mucosal mononuclear immune cells, T cells and 
mast cell numbers, pro-inflammatory cytokines and increased intestinal 
permeability, are frequently observed in IBS patients
38
. It has also been 
suggested that the extent of immune activation in prior history of 
gastrointestinal infection is an indicator of the severity of the infective 
gastroenteritis episode and the subsequent risk of developing IBS
38,55,56
. 
Soluble mediators secreted from degranulated mast cells in colonic mucosa of 
IBS patients were found to induce excitation of rat sensory neurons
38,57
, and 
the proximity of activated mast cells to colonic mucosal innervation was found 
to correlate with visceral pain severity in IBS patients
38,58
. In addition, the 
neurotransmitter serotonin is also secreted by mast cells and so elevations in 
mast cell numbers may provide a link between cellular infiltrate and altered 
serotonin signalling, leading to changes along the brain-gut axis and 




In the wake of an enteric infection, pathogen-mediated disruptions of the 
mucosal barrier may lead to persistent immune activation within the intestine, 
largely due to increased exposure to luminal antigens. Likewise, the host 
inflammatory response towards perceived pathogens, while meant to be 





. A systematic review and meta-analysis of nine 
case-control studies showed that serum and plasma levels of TNF-α are 
significantly higher in IBS subtypes vs controls and in women with IBS and 
serum/plasma IL-10 levels are significantly lower in men with IBS
59
. Colonic 





In a study using a mouse model for Trichinella spiralis infection, cellular 
elements of mucosal immunity like dendritic cells that reside in the lamina 
propria continue to show heightened expression of co-stimulatory markers 
even after the active phase of infection, when the pathogen responsible for the 
earlier infection was no longer detected.
54
. Upon invasion by the obligate 
intracellular pathogen Shigella, regulatory macrophages in the lamina propria 
that serve an anti-inflammatory role commit to pyroptosis, an inflammatory 
form of programmed cell death, diminishing populations of these cells, to be 
replaced by more pro-inflammatory macrophages differentiated from 
monocytes
54,60
. Taken together, it is possible that these pathogen-mediated 







1.5  INNATE IMMUNOLOGICAL RESPONSES AGAINST 
EUKARYOTIC PATHOGENS 
The innate arm of host immunity is the first line of defence against several 
known eukaryotic pathogens of fungal and protistan species. As described 
above, innate immunological responses are initiated from several classes of 
receptors that detect conserved pathogen-derived molecular patterns and 
mediators. Receptors such as surface and endosomal membrane bound TLRs 
and cytoplasmic NLRs and RLRs activate downstream signalling pathways 
towards specific effector responses. TLRs detect a wide array of microbial 
factors, most of them of bacterial and viral origin
61
. Only TLR-2, -4,-9 and -11 
have been found to be able to detect molecular patterns from eukaryotic 
pathogens like fungi and Protozoa
61
. NLRs such as NLRP3 and NLRP10 
regulate the formation of the inflammasome and contribute to initiation of 
downstream Th17 responses respectively and are known to be involved during 
infections by the kinetoplastid Leishmania major and the yeast Candida, or in 
the presence of parasite factors like malarial hemozoin
61–64
.  The RLRs RIG-I, 
MDA5, and LGP2 are primarily involved in sensing for nucleic acids of viral 
pathogens and driving host immune responses against them
65
. There is 
currently no known ligand of eukaryotic origin that interacts with RLRs. 
 
Besides receptor-based immunosurveillance for pathogen-associated 
molecular patterns, cellular elements of innate immunity also produce reactive 
molecular intermediates, such as reactive oxygen species (ROS) and reactive 
nitrogen species (RNS), to combat invading pathogens. During infection, 
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several proinflammatory mediators stimulate the generation of ROS or RNS 
by macrophages and neutrophils that infiltrate the sites of inflammation
66,67
. 
For instance, following Leishmania infection, phagocytosis by macrophages 
promotes NADPH oxidase complex-driven generation of superoxide, a 
precursor to several different reactive oxygen species during respiratory burst, 
or through the inducible nitric oxide synthase (iNOS) pathway
68
. 
Alternatively, nitric oxide (NO) synthesis from L-arginine is mediated by 
IFNγ and effectively hinders cellular multiplication of Toxoplasma gondii, as 
arginine is depleted during NO production
69
. Giardia, a non-invasive, luminal 
enteric extracellular parasite is known to inhibit intestinal epithelial iNOS 
activity, via a similar mechanism as other extracellular pathogens like 
Helicobacter pylori and Entamoeba in macrophages, through direct 




Granulocytes such as eosinophils, neutrophils and basophils secrete toxic 
cationic proteins and have an active role against infections of multicellular 
organisms like helminths and nematodes. Eosinophilic granules are primarily 
composed of the following cytotoxic, cationic proteins: major basic protein, 
eosinophil peroxidase, eosinophilic cationic protein and eosinophil-derived 
neurotoxin
72
. Activated eosinophils undergo classical exocytosis, in which 
granule contents are completely released by fusion with the cellular 
membrane, cytolysis, in which the plasma membrane ruptures and granules are 
deposited out of cells; or via “piecemeal degranulation”, in which vesicles bud 
from granules and are trafficked through the cytoplasm to the cell membrane 
for release of contents
72
. Neutrophils are often the first cell type recruited to 
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the site of an acute inflammatory response. They are characterized by their 
phagocytic activity via complement receptor 3 and FcγR that binds 
complement C3b and IgG on surfaces of opsonized pathogens
73
, release of 
lytic enzymes and eosinophil chemotactic factors, and the production of ROS 
with anti-microbial potential
72
. Basophils may be important in DC-mediated 





1.6 ADAPTIVE IMMUNOLOGICAL RESPONSES AGAINST 
EUKARYOTIC PATHOGENS 
Initiation of adaptive immune responses begins with antigen processing and 
presentation to naïve T lymphocytes. The major antigen presenting cells are 







 intestine‑resident macrophages function as 
avid phagocytes to mediate clearance of pathogens and commensal bacteria 
that traverse the epithelial barrier
40
. Gut macrophages are derived exclusively 
from recruited blood monocytes, and, after terminal differentiation, they 
become resident macrophages in the mucosa of the small intestine and the 
colon
74
. Elevations in macrophage number has been observed  during mucosal 
infection and this has been attributed to the recruitment of  monocytes from 
circulation to the site of inflammation, which then differentiate into 
proinflammatory macrophages
74
. Proinflammatory macrophages produce 
TNF-α and other proinflammatory mediators such as IL-6 and iNOS in 
response to pathogens, and promote effector T lymphocyte function through 
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production of cytokines like IL-12 and IL-23
75
. This presence of IL-12 and IL-
23 suggests that activated intestinal macrophages with a proinflammatory 





In the case of gut DCs, CD103
+
 DCs act as migratory antigen-presenting cells 
and upon activation, traffic to secondary lymphoid tissues, including the 
mesenteric lymph nodes and Peyer’s patches, carrying with them antigenic 





. DCs have been found to be activated by several 
eukaryotic pathogens such as Entamoeba histolytica
76
 and Giardia lamblia
77
. 
Entamoeba histolytica drives DC activation and downstream initation of Th1 T 
lymphocyte differentiation via the parasite's surface galactose-N-acetyl-D-
galactosamine inhibitable lectin
76
. Giardia lamblia actively interferes with 
host innate immunity through phosphoinositide 3-kinase-dependent inhibition 
of IL-12 production, resulting in an immune response able to control the 
infection but devoid of strong inflammatory signals. 
 
Initiation of B cell-mediated humoral response against pathogens is largely 
driven by prior priming of naïve CD4
+
 T cells through antigen presentation by 
DCs, ligation of co-stimulatory factors and cytokine pressure. IgA is the 
dominant antibody class of mucosal surfaces and the development of B cells 
into mature IgA-secreting plasma cells through heavy chain class-switch 





1.7 HOST IMMUNOLOGICAL RESPONSES AGAINST 
BLASTOCYSTIS SPP. 
Blastocystis spp. It is observed to have numerous effects on colonic epithelia 
on which it colonizes. It has been found to degrade secretory immunoglobulin 
A
78
, mediate epithelial F-actin rearrangement leading to epithelial barrier 
disruption
79
, induce NO production
70
 and induce significant production of the 
chemokine IL-8
80
, a chief chemoattractant of neutrophils. In vivo model 
studies involving rats have reported intense inflammatory reaction and 
sloughing off of intestinal mucosa
81
; and significant up-regulation in 
expression of the proinflammatory cytokines IFNγ, IL-12, TNF-α in the caecal 
mucosa after RT-qPCR analysis
35
. Recently, one study demonstrated through 
mouse models and in vitro studies with murine macrophage RAW264.7 cells 
that isolates from Blastocystis spp. subtypes 4 and 7 are capable of inducing 
abundant expression of pro-inflammatory cytokines IL-1β, IL-6 and TNF-α 
via activation of the MAP kinases ERK and p38
82
. The same study also found 
for the first time that ST7-B serine proteases play a major role in the activation 





1.8 STUDY OBJECTIVES 
While the number of reports of Blastocystis-mediated effects on colonic 
epithelia grows in literature and basic studies done to map out Blastocystis-
mediated immunological effects on the host have contributed to a nascent 
understanding of the pathogenicity of the parasite, almost all remained focused 
on the context of colonic epithelial cells and interactions between Blastocystis 
spp. and cellular elements of host immunity remain poorly studied.  
 
Colonic epithelial cells perform protective functions not only as a physical 
barrier against invading pathogens, but also as active participants in innate 
immunity
83
. They express several TLRs, including TLR-2, -4, -5 and -9
83
. 
These TLRs upon sensing the presence of specific factors from microbial 
pathogens, activate inflammatory pathways. We hypothesize that TLRs 
contribute to the onset of inflammation by Blastocystis, previously observed in 
earlier in vitro
80,84
 and in vivo
35,82
 studies. It is currently unknown if 
Blastocystis spp. activates TLRs or has any modulating effects on TLR 
signalling. By studying the interactions of Blastocystis spp. on TLRs relevant 
to gut mucosa, we aim to use this approach to obtain preliminary insights into 
effects of Blastocystis spp. on TLR signalling. In the broader picture, such 
effects may bring better resolution into understanding how Blastocystis spp. 
perturbs intestinal immune homeostasis and its association with 
immunopathologies like IBD, and gastrointestinal disorders likes IBS, of 






Besides intestinal epithelial cells, TLRs are expressed by several different 
types of immune cells. Immune cells that are resident along intestinal mucosa 
and play vital sentinel roles in regulating intestinal homeostasis include the 
intestinal macrophages and dendritic cells described above
40
. Dendritic cells 
are the most efficient antigen presenting cells and are the dominant cell type 
involved in the transition of the host immune response from innate to adaptive 
elements of immunity, though the activation and proliferation of naïve CD4
+
 T 
cell populations. Specific dendritic cell populations have been found to closely 
associate with the colonic epithelium and are also active in sampling luminal 
contents for pathogenic factors
86
. After contact with pathogens and pathogenic 
factors, mucosal DCs undergo activation and maturation and migrate to 
secondary lymphoid organs like the mesenteric lymph nodes, where they 
present antigen and induce innate immune responses. Blastocystis has been 
associated with extra-gastrointestinal immunopathological symptoms like 




Interactions between Blastocystis spp. and dendritic cells remain a neglected 
area of study and findings from investigations into this area, taken together 
with reported observations of Blastocystis-mediated induction of mucosal 
inflammation, would provide a more comprehensive characterization of 
effects from the parasite at the mucosal microenvironment and beyond, into 
the host responses mounted against it. Towards this end, this study aims to 
improve understanding of mechanisms underlying host-microbe interactions 
during a Blastocystis infection that contribute to the induction of host 
immunity, specifically of upstream sensory elements like TLRs and also in 
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dendritic cells, an immune cell type that holds crucial roles in both innate and 













BLASTOCYSTIS SPP. SUBTYPE 4-WR1 





Blastocystis as a genus possesses high genetic diversity and previous species 
classification conventions had been largely based on the host organism from 
which the parasite was isolated from
19
. More recently, genetic approaches 
were increasingly used to map phylogenetic relationships among the many 
isolates obtained from a wide variety of host sources
5
. This led to the 
emergence of groups of isolates, depending on which of the several proposed 
identifying methodologies was employed
5
. However, it was shown that 
previously used host-based species nomenclature was inconsistent with the 
identifying methodologies based on genetics analyses, as a particular group of 
isolates may involve more than one type of host organism, and also that a 
single host species like Homo sapiens can harbour members from more than 
one group of isolates
19
. This left previous naming conventions like 
Blastocystis hominis less meaningful in efforts to correlate possible 





Accepted by many as a solution to this, a new consensus terminology
5
 was 
proposed over the last decade that offered improve communication and 
correlate research results. Under this methodology, Blastocystis spp. was 
widely accepted as a species complex, in which isolates from human and 
animal hosts was categorised into 9 subtypes
5
. Currently, the classification has 
been expanded to 17 subtypes, 9 of which infect humans
6
. Infections with 
Blastocystis spp. are usually associated with gastrointestinal symptoms such as 
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diarrhoea, abdominal pain and vomiting
25
, although a large proportion of 





Out of subtypes 1 to 9 that have been observed in humans, epidemiological 
data attributes a large proportion of human infections to subtypes 1, 2, 3 and 4, 
with subtypes 6 and 7 being commonly observed in Asia and subtypes 5, 8 and 
9 being only periodically observed in human populations
4
. The pathogenicity 
of Blastocystis spp. and its status as a pathogen are still subjects of open 
discussion and debate in literature
4,7,25,88
, and difficulties in achieving 
breakthroughs in understanding of the role of Blastocystis spp. as a pathogen 
are compounded by the complex and varying geographical profile of the 
prevalence of different Blastocystis spp. subtypes. Comparative studies may 
be conducted to investigate host-pathogen interactions between clinically and 
epidemiologically relevant Blastocystis subtypes and host tissue in in vitro and 
in vivo settings, but differences in cellular characteristics and physiology, if 
any, should be uncovered and taken into consideration between subtypes to 
allow for comparable experiments to investigate degrees of pathogenicity 
among the different subtypes. 
 
In this chapter, experiments were carried out to highlight differences between 
two axenic Blastocystis isolates, B and WR1, from subtypes 7 and 4 
respectively. Subtype 4 has been found to be of high prevalence in several 
parts of Europe, with varying associations with the manifestation of 
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gastrointestinal symptoms in patients. In contrast, subtype 7 is common in 
Asia. Subtype 7 is also the next most prevalent subtype after subtypes 1, 2, 3 
and 4, which have been identified as the most common subtypes across several 
epidemiological studies. These two subtypes are clinically relevant, with 
different degrees of association to gastrointestinal symptoms, and successful 
axenization of pure isolates from symptomatic patients in the case of subtype 
7.  
 
In addition, to aid in comparative studies, pure and axenic isolates of subtype 
4 are available, which had been obtained from asymptomatic rats. The 
comparison of subtype 7 isolates that were obtained from a symptomatic 
source, with subtype 4 isolates from an asymptomatic one, offers a focused 
comparative investigation to better understand possibly differing 
pathogenicities of Blastocystis spp. Parameters like cell sizes and intracellular 
protein content were measured from cells of isolates B and WR1 of subtypes 7 
and 4 respectively. A means of tagging live parasites by fluorescence through 
carboxyfluorescein diacetate succinimidyl ester (CFSE) labelling was also 








2.2  MATERIALS AND METHODS 
2.2.1 Parasite culture 
In vitro cultures of axenic isolates representative of 2 Blastocystis spp. 
subtypes were maintained in pre-reduced Iscove’s modified Dulbecco’s 
medium (IMDM) (Hyclone), with 10% heat-inactivated horse serum (Gibco). 
Isolates used in this study were subtype 4-isolate WR1 (ST4-WR1) and 
subtype 7-isolate B (ST7-B). ST7-B was previously isolated from a patient 
with gastrointestinal symptoms at Singapore General Hospital and maintained 
as an axenic culture
78,89
. ST4-WR1 was previously isolated from 
asymptomatic Wistar rats and maintained in axenized culture
26,78,90
. Culture 
tubes were housed in anaerobic jars (Thermo Scientific-Oxoid) at 37
o
C. 
Parasites were sub-cultured every 3-4 days and 1 day old parasites were used 
directly for co-culture experiments or preparation of parasite lysate. Light 
micrographs of live ST4-WR1 and ST7-B parasites were taken using an 
Olympus BX60 upright microscope. (Olympus, Japan). 
 
2.2.2 Parasite lysate preparation 
1 day old parasites were harvested from culture tubes and washed twice in 
sterile phosphate-buffered saline (PBS) (pH 7.4). Parasites were then counted 
using a haemocytometer and subjected to 3 freeze-thaw cycles in liquid 
nitrogen and 37
o
C water bath. Lysate aliquots were stored at -80
o





2.2.3  Size segregation of parasites     
Live ST4-WR1 and ST7-B parasites were subjected to sequential 
centrifugations: in the order of 300 × g, 5min; 1100 × g, 10min; 2000 × g, 
10min; with supernatant collected after each centrifugation step to be used for 
the next one. Sizes of pelleted parasites from each centrifugation step were 
verified by forward scatter analysis (FSC) via flow cytometry. Viability of 
cells after each centrifugation was assessed by propidium iodide (PI) staining. 
Healthy parasite cells are negative for PI staining and used for co-culture 
experiments. 
 
2.2.4  Protein quantification of parasites 
Parasite lysate aliquots were first centrifuged at 20000 × g for 30 min at 4
o
C to 
obtain soluble protein fraction that constitute the supernatant from the 
centrifugation step. Supernatant was collected into sterile new microcentrifuge 
tubes and diluted 1:10 with cold sterile PBS. Protein content was measured 
using the Bio-Rad DC™ (detergent compatible) Protein Assay (Bio-Rad). 
Standards for the assay were bovine serum albumin (BSA) (Santa Cruz 
Biotechnology) dissolved in sterile PBS at concentrations according to 
manufacturer’s recommendations. 
 
2.2.5  Phylogenetic analysis of subtypes and isolates 
Small subunit ribosomal RNA sequences of isolates representing subtypes 1, 
2, 3, 4 and 7 were derived from GenBank. Multiple sequence alignment 
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analysis was carried out using MUSCLE
91
 and phylogenetic tree was 
constructed by neighbour joining. All multiple sequence alignment analysis 
and phylogenetic tree generation were carried out in a continuous workflow on 
the web service Phylogeny.fr
92–94
. Values indicate bootstrap values calculated 
from 1000 trees, as decimals of 1, with 1 corresponding to a bootstrap value of 
100. Proteromonas lacerate was used as the outgroup. 
 
2.2.6  Carboxyfluorescein diacetate succinimidyl ester (CFSE) labelling         
Fluorescent staining of live parasites is needed for downstream experiments 
described in Chapter 4. To this end, live parasites were labelled with stable 
cell-permeable viability dye CFSE. 1 day old parasites were harvested and 
washed twice in sterile PBS before being labelled with 20µM CFSE for 10min 
at 37
o
C. Labelled parasites were then washed twice with 10 volumes sterile 
PBS before use in subsequent experiments. 
 
2.2.7  Statistical analysis 
Experiments were repeated independently at least twice. Experimental data are 






2.3.1  Phylogenetic differences between subtypes and isolates 
Two isolates of Blastocystis spp., WR1 and B, representing subtype 4 and 7 
respectively, were used in comparison in this chapter. It should be noted that 
both isolates have distinctly different isolation origins, WR1 being from an 
asymptomatic source whereas B was from a patient with gastrointestinal 
symptoms. Both isolates and the subtypes they represent show differing 
degrees of divergence across the different subtypes sampled for phylogenetic 
analysis of the 18S small subunit ribosomal RNA gene (Figure 2.1; Table 2.1). 
Our analyses suggest that ST7 diverged early from ST1-4, after divergence 
and speciation from other stramenopiles like Proteromonas lacerate. Among 
ST1-4, a pairwise divergence event occurred between ST1 and ST2 from ST3 
and ST4, before each of these four subtypes diverged into its own 
phylogenetic branch.   
 
2.3.2  Cell size differences between ST4-WR1 and ST7-B 
In vitro cultures of Blastocystis spp. have been observed to exhibit non-
uniformity in cell size
95
. In that study, measurements were done by comparing 
forward scatter profiles of individual cultures with forward scatter peaks 
generated using polyvinyl beads of five defined diameters (3µm, 6µm, 8µm, 
10µm, 15µm). At each of the five different time points (0, 24, 48, 72, 96 
hours), parasite culture pellets were re-suspended and appropriately diluted for 
measurement of cell counts and cell diameter. It was observed, in that study, 
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that cellular size of ST4-WR1 range from 3-8µm and that of ST7-B ranged 
from 3-15 µm. Presently, light micrographs taken of live samples direct from 
in vitro cultures were able to show such differences between isolate WR1 of 
subtype 4 and isolate B of subtype 7 (Figure 2.2). Separate populations of 
large and small parasites were needed in subsequent experiments. To that end, 
live parasites were subjected to consecutive centrifugation spins at speeds 
optimised to separate large from small cells. From FSC histogram overlays, it 
was observed that cell size ranges of ST4-WR1 parasites was smaller than that 
of ST7-B parasites, both in pelleted cells after the first centrifugation, when 
largest cells are first pelleted down, and also in the last centrifugation of 
greatest speed at 2000 × g for the enrichment of small cells (Figure 2.3). Light 
micrographs of samples of pelleted cells after the first and last centrifugation 
confirm that through this procedure, viable small and large parasites are 
separated and that this method could be applied to isolates of different 
subtypes (Figure 2.4). Therefore, in the context of cell size, taking together 
previously reported cell size ranges for ST4-WR1 and ST7-B and data 
observed in this study that is consistent with those earlier reported findings, 
the ratios of 1 host cell to 10 live parasites and 1 host cell to 20 live parasites 
were used in this study for ST7-B and ST4-WR1 respectively for subsequent 
experiments. 
 
2.3.3  CFSE uptake by ST4-WR1 and ST7-B 
Recommended working concentrations during CFSE labelling of viable cells 
range from 5 to 25µM
96
. CFSE labelling of live Blastocystis ST4-WR1 and 
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ST7-B parasites was carried out at 20µM. Labelled parasites were observed to 
have taken up the dye readily and cell morphologies have not been affected 
post-labelling, with ST4-WR1 cells appearing as smaller fluorescent spheres 
compared to ST7-B (Figure 2.5). CFSE labelled parasites also retained high 
fluorescence after incubation in complete media for 6 hours.  
 
2.3.4  Protein quantification of ST4-WR1 and ST7-B 
In addition to cell size, intracellular protein content was also compared 
between ST4-WR1 and ST7-B. Similar numbers of live parasites (1 × 10
7 
cells) from isolate WR1 and B cultures of similar age were subjected to lysis 
and the soluble protein fraction was subjected to protein quantification. We 
observed that the protein content of ST7-B parasites (2.47mg/ml) to be 






Fig 2.1. Phylogenetic analysis on 18S small subunit ribosomal RNA 
sequences of isolates of Blastocystis subtypes 1, 2, 3, 4, 7. Values denote 













[1]Sequences adapted from Scicluna et al. (2006)
97
  
[2]Unpublished sequences directly submitted to GenBank by Jones et al. (2008)  
[3]Unpublished sequences directly submitted to GenBank by Stensvold and Clark 
(2011)  











Table 2.1     Subtypes and isolates used in phylogenetic analysis of small 
subunit ribosomal RNA gene 






























































Fig 2.2. (A) Light micrographs of live Blastocystis spp. ST4-isolate WR1 and 
ST7- isolate B parasites at 40× magnification. Scale bar: 10µm. Note the 
qualitatively larger average size of ST7-B cells compared to ST4-WR1 cells. 
(B) Line charts showing cell size range of ST4-WR1 and ST7-B parasites 
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Fig 2.3. Separation of live ST7-B and ST4-WR1 parasites by size using 
sequential cell density centrifugation at increasing speeds. Forward scatter dot 
plots of parasites pelleted after each centrifugation step and histogram 
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Fig 2.4. Light micrographs of separated large and small live Blastocystis spp. 
ST4-WR1 and ST7-B parasites at 40× magnification, of cells pelleted from the 
first centrifugation (300×g) and third centrifugation (2000×g). Note the 



















Fig 2.5. Light and fluorescence micrographs of live CFSE-labelled parasites at 
20× magnification. Selected fields (boxes) were magnified further to 40× and 
shown in corresponding frames to the left (Red frames).   
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Fig 2.6. (A) Fluorescence micrographs of CFSE-labelled live ST4-WR1 and 
ST7-B parasites at 20× magnification. High fluorescence signals were retained 
by both isolates after 6 hours post-labelling. (B) Verification of parasite 
viability after CFSE labelling by fluorescence-based resazurin cell viability 
assay. Bar chart represents mean fluorescence emission intensities at 580nm 
from both unlabelled parasites and CFSE-labelled parasites. Error bars 
represent standard deviations of mean fluorescence intensities from triplicates 
in one experiment. CFSE labelling was not observed to have a significant 









Fig 2.7. Protein quantification assay of ST4-WR1 and ST-7 lysates. Equal 
numbers (1 × 10
7
 parasites) of 1 day old ST4-WR1 and ST7-B were lysed and 
measure for protein content. Bar chart represents mean protein content 
(mg/ml) and error bars represent standard errors of the means. Note the 
marked difference in intracellular protein content between ST7-B and ST4-





The 2 subtypes studied in this chapter are each represented by isolates that 
originated from distinctly unique sources. Isolate WR1 of subtype 4 was 
obtained from Wistar rats that were asymptomatic carriers of the parasite 
during an animal survey
26,90
, whereas isolate B of subtype 7 was obtained 
from a patient who presented with gastrointestinal symptoms at Singapore 
General Hospital. Both isolates represent subtypes that have been detected in 
human hosts and are therefore relevant in discussions on the pathogenicity of 
Blastocystis spp. 
 
Recently, subtype 4 has been reported to be prevalent in several parts of 
Europe
99–101
. In one study, despite the high prevalence of subtype 4 reported, 
no correlation was found between symptomatic patients, immune status and 
parasite load
100
. However, in another recent study, subtype 4 was found to be 
the most common subtype detected from a sampling of clinical isolates from 
symptomatic patients in Spain
99
. Apart from the high prevalence reported of 
subtype 4 in that sampling, the authors made no claim of significant 
correlation of subtype 4 to the presence of gastrointestinal symptoms in the 
patients, but suggested that the subtype may contain both pathogenic and non-
pathogenic variants
99
. Another recent survey of patients presenting with acute 
diarrhoea in Denmark reported high prevalence of subtype 4 and 
recommended that the role of Blastocystis spp. ST4 in the aetiology of acute 





Compared to subtype 4, subtype 7 is common in Asia but has rarely been 
detected in European countries
4
. Recent prevalence surveys suggest that 
subtype 7 is the next most prevalent subtype, after subtypes 1 to 4 which are 
the common subtypes detected across several epidemiological studies
4,102
. 
Like subtype 4, this subtype has been shown to be zoonotic. Isolates classified 
under subtype 7 have been obtained from both humans and avian sources, with 
a recent survey performed on livestock and a wide variety of animal species in 
zoological conservation settings detected subtype 7 in goats and a variety of 




Studies investigating pathogenicity of these 2 subtypes have yielded findings 
that contribute to the current hypothesis that degrees of pathogenicity differs 
among subtypes. Isolates WR1 and B, of subtypes 4 and 7 respectively, were 
found to both be capable of degrading human secretory igA, although isolate 
B-mediated degradation was mainly by cysteine proteinases whereas isolate 
WR1-mediated degradation was by aspartic proteinases
78
. Extensive subtype-
dependent variations in susceptibilities to the drug metronidazole were 
reported among subtype 4 and 7, with subtype 7 being found to be resistant to 
it
103
. The same group also uncovered associations between metronidazole 
resistance in subtype 7 with increased sensitivity to nitric oxide, and that 
subtype 7, not subtype 4, was capable of downregulating intestinal epithelial 
inducible nitric oxide synthase
70
. More recently, further differences between 
subtype 4 and 7 were characterised.  Subtype 7 was found to be more adhesive 
to colonic epithelial cell monolayers and only subtype 7 and not 4 was capable 
of significant disruption of ZO-1 and occludin tight junction proteins as well 
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as increased dextran-FITC flux across epithelial monolayers
104
. The same 
group also showed that subtype 7, but not subtype 4, significantly increased 
apoptosis in enterocytes in a caspase 3- and 9-dependent manner.  
 
In this and subsequent chapters, isolates WR1 and B were used to represent 
subtypes 4 and 7 respectively in a series of comparisons between Blastocystis 
from asymptomatic and symptomatic host origins. These comparisons would 
contribute towards understanding different effects, if any, of the parasite on 
host elements from isolates obtained from asymptomatic or symptomatic 
sources. It is also hoped that a characterization of differential effects from 
Blastocystis spp. associated with healthy or diseased individuals would 
provide an initial picture of how host elements like the intestinal mucosa and 
immune system respond after Blastocystis challenge.        
 
Due to the current classification status of Blastocystis spp. as a genetically 
diverse species complex comprising of many isolates classified into numerous 
subtypes and its high prevalence in the global human population, the 
pathogenicity of this common parasite remains controversial. Previous basic in 
vitro and in vivo studies investigating effects of Blastocystis spp. on host cells 
have largely focused on isolates from a single subtype
35,80,105
, or have 
attempted comparisons between isolates from different subtypes
81,104,106
. 
Studies involving the latter usually use similar parasite loads across the 
subtypes of interest to expose to host cells, as a way of equal comparison by 
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number of live parasites or the number of parasites that corresponded to the 
amount of parasite lysate tested with host cells.  
 
Comparison only by whole cell numbers precludes other aspects of 
Blastocystis spp. cell biology that might differ between isolates and subtypes. 
Some of these aspects include cell size and cellular protein content. 
Differences in cell size have been reported between isolates of subtypes 4 and 
7, in which cell sizes of subtype 7 isolates were found to be consistently larger 




In addition, these variations were not only seen across subtypes but also within 
single isolates. In this study, we attempted to separate parasites based on cell 
size by subjecting laboratory cultures of numerous centrifugation conditions. 
This resulted in the division of cultures of each isolate into fractions 
containing live parasites of cell sizes that held an inverse correlation with 
centrifugation speed.   
 
Besides cell size, variations in Blastocystis cysteine protease activity were also 
previously observed
95
 but there have been no further attempts to investigate 
variations in intracellular cysteine protease or total protein levels. We report 
differences in intracellular protein content between ST4-WR1 and ST7-B. 
Superficially, these differences do not contradict previously observed 
variations in cell size ranges of the 2 isolates
95
 and it is within expectations 
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that parasite isolates with larger cell size ranges contain more protein than 
smaller isolates. In addition, the observation of denser and more granular 
cytoplasm in ST7-B compared to ST4-WR1 might be attributed to ST7-B 
containing much higher protein content than ST4-WR1. Principally, it is worth 
noting that the almost 5-fold difference in protein content between ST4-WR1 
and ST7-B should be taken into consideration when planning parasite loads 
against host cells in subsequent studies. 
 
With the characterization of measurable parameters of cell size and 
intracellular protein content between ST4-WR1 and ST7-B, experiments were 
then designed to provide a more comprehensive and equitable comparison 
between subtypes 4 and 7 in altering the inflammatory state of the colonic 












MODULATION OF TOLL-LIKE 
RECEPTOR ACTIVATION IN 
SURROGATE MODEL OF THP1-BLUE 




Symptomatic carriers of Blastocystis spp. present with typical gastrointestinal 
symptoms such as diarrhoea, abdominal pain, flatulence, vomiting and 
bloating
25
. The parasite has also been implicated in allergy-associated 
dermatological conditions and irritable bowel syndrome (IBS)
88,107
. However, 
most human carriers of Blastocystis spp. remain asymptomatic, especially 




Regardless, an increasing number of reports, including those that were covered 
above, have begun to provide a better understanding of the pathogenesis of 
Blastocystis spp. and to confirm its status as an emerging pathogen. Earlier 
studies reported that some isolates of Blastocystis spp. are capable of 
degrading human secretory IgA
78
; and promote contact-independent apoptosis, 
F-actin rearrangement and barrier function disruption in a non-transformed rat 
intestinal epithelial cell line
79
. More recently, cysteine proteases of the parasite 
are reported to induce rho kinase-mediated intestinal epithelial barrier 
compromise in human colonic epithelial cells
105
. Despite these reports, much 
still remains to be understood about interactions between Blastocystis spp., 
host colonic epithelia and associated gut mucosal immunity.  
 
Toll-like receptors (TLRs) are a family of pathogen recognition receptors that 
play a vital role in innate immune-surveillance of microbial molecular 
patterns. All TLRs share three similar structural features: a divergent ligand-
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binding extracellular domain with leucine-rich repeats, a short transmembrane 
region, and a highly homologous cytoplasmic toll/interleukin (IL)-1 receptor 
domain that is similar to that of the IL-1 receptor family and is essential for 
initiation of downstream signalling cascades
108
. Thirteen TLRs have been 





TLRs in the intestinal mucosa are able to rapidly recognize luminal pathogens 
and their associated molecular patterns, while still maintaining 
hyporesponsiveness to persistently present populations of harmless 
commensals
108
. Upon activation by pathogen-associated factors, TLRs activate 
downstream signalling cascades which mediate the activation of transcription 
factors such as NF-κB and culminate in the upregulation of immune response 
genes, such as those of pro-inflammatory cytokines and chemoattractant 
chemokines to facilitate immune cell infiltration to the site of infection. Recent 
studies also suggest possible immune-regulatory roles of TLRs towards 
maintenance of intestinal homeostasis by regulating barrier function and 
modulating mucosal immune response; and management of intestinal injury 
through promoting the proliferation of intestinal epithelial cells
39
. We 
hypothesize that given the various effects of Blastocystis spp. on host 
intestinal epithelial cells, it is likely that the parasite would have a 
dysregulating effect on TLR signalling, contributing towards a disruption of 




It is currently unknown if Blastocystis spp. activates TLRs or has any 
modulating effects on TLR signalling. In the current chapter, we employed 
THP1-Blue, a commercially available human monocytic TLR reporter cell line 
to investigate Blastocystis effects on TLR activation. The THP1 human 
monocytic cell line naturally express many pattern recognition receptors, 
including TLRs. THP1-Blue cells are modified from this cell line via a stable 
transfection of a reporter plasmid that expresses a secreted embryonic alkaline 
phosphatase (SEAP) gene under the control of a promoter inducible by NF-
κB. By studying the interactions of Blastocystis spp. on TLRs relevant to gut 
mucosa, we aim to use this approach to obtain preliminary insights into 




3.2 MATERIALS AND METHODS 
3.2.1 THP1-Blue human monocytic cell line  
In this chapter, the THP1-Blue human monocytic cell line (Invivogen) was 
used for all experiments investigating Blastocystis-host interactions. THP1-
Blue cells were maintained in T-75 flasks in a humidified incubator at 37
o
C 
and 5% CO2. The THP1-Blue cells were cultured in Roswell Park Memorial 
Institute (RPMI) 1640 (Gibco) supplemented with 100U/ml penicillin and 
100µg/ml streptomycin (PAN-Biotech) and 10% heat-inactivated fetal bovine 
serum (Gibco). Culture viability was evaluated every 3-4 days using the trypan 
blue assay and only cultures with >95% viability were used for experiments. 
 
3.2.2 THP1-Blue cell viability assay 
Viability of THP1-Blue cells was studied by annexin V-fluorescein 
isothiocyanate (FITC)-propidium iodide (PI) staining with an Annexin V-
FITC Apoptosis Detection Kit (Biovision), following closely the 
manufacturer’s protocol recommendations. 5µM staurosporine (STS) was 
used as a positive control to induce cell death. Briefly, THP1-Blue cells were 
washed and resuspended in annexin V binding buffer from the kit after 
exposure to various experimental conditions described above. FITC-labeled 
annexin V and PI were then added to the cell suspension. Stained THP1-Blue 
cells were then subjected to flow cytometric analysis. In flow cytometric 
analysis, the THP1-Blue cell population was differentiated from live parasites 
by specific size gating applied to non-overlapping populations visualised on 
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forward scatter vs side scatter dot plots. Offline flow cytometric analysis was 
carried out using FlowJo Ver. 7.6.4. 
 
3.2.3 Secreted embryonic phosphatase (SEAP) activity assay 
In this chapter, unless otherwise stated, THP1-Blue cells were exposed to live 
parasites and parasite cell lysate at the ratio of 1 THP1-Blue cell to 10-20 
parasites for 24 hours under THP1-Blue culture conditions (37
o
C and 5% 
CO2). 1µg/ml purified lipopolysaccharide (LPS) from Salmonella enterica 
serotype typhimurium (Sigma Aldrich), 5µg/ml purified zymosan (ZG) from 
Saccharomyces cerevisiae (Invivogen) or 0.5 µg/ml purified flagellin (Fla) 
from Salmonella enterica serotype typhimurium (Invivogen) were used in 
conjunction with live parasites or parasite cell lysate in co-culture conditions 
with THP1-Blue cells. Culture supernatant was collected and incubated with 
QUANTI-Blue substrate medium for 2 hours at 37
o
C. SEAP activity was then 
assessed by colorimetric change (figure 1A) in the substrate medium and 
absorbance reading at 655nm with an Infinite M200 microplate reader 
(Tecan). 
 
3.2.4 Real-time quantitative PCR 
After exposure to parasite lysate, total RNA was extracted from THP1-Blue 
cells using the RNeasy Mini Kit (Qiagen). 1µg total RNA was reverse-
transcribed using iScript Reverse Transcription Supermix for RT-qPCR (Bio-
Rad). Reverse transcription reactions were incubated at 25
o





for 30 min and lastly, 85
o
C for 5 min. Real-time quantitative PCR was run in 
Bio-Rad iQ5 Multicolor Real-Time PCR Detection System (Bio-Rad) with 
iTaq Universal SYBR® Green Supermix (Bio-Rad). The real-time 
quantitative PCR primer used to target the SEAP gene is as follows: forward, 
5’-AGAACCTCATCATCTTCCTG-3’; reverse, 5’-
TCCTTCTTCTGCCCTTTTAG-3’. Messenger RNA (mRNA) levels were 
normalized against glyceraldehyde-3-phosphate dehydrogenase (GADPH). 
 
3.2.5 Statistical analysis 
Experiments were repeated independently at least twice. Experimental data are 






3.3.1 Viability of THP1-Blue 
In direct cell-to-cell exposure of THP1-Blue cells to live Blastocystis 
parasites, firstly the possibility that Blastocystis spp. inducing cell death in 
THP1-Blue was explored. Viability of THP1-Blue cells after 24 hour exposure 
to live parasites was assessed by flow cytometry analysis of AnnexinV-FITC, 
PI staining. Viability of THP1-Blue cells was found to decrease slightly 
[81.55-92.74%] after being exposed to live ST7-B and ST4-WR1 parasites 
(Figure 3.1A). Viability of THP1-Blue cells was also assessed after exposure 
to parasite lysate. Unlike the slight decrease observed in the case of exposure 
to live parasites, THP1-Blue viability remained at highly similar levels to that 
of unchallenged THP1-Blue cells after incubation with parasite lysate or 
specific TLR ligands (Figure 3.1B). 
  
3.3.2 TLR ligand-specific NF-κB activation of THP1-Blue cells 
THP1-Blue cells were first assessed for their responsiveness to specific TLR 
ligands. Here, we exposed THP1-Blue cells to zymosan, flagellin and LPS, 
which are specific ligands for TLR-2, -5 and -4 respectively (Fig 3.2A). SEAP 
activity, a measure of NF-κB activation, was assessed through absorbance 
measurements after colorimetric changes (Fig 3.2B) to substrate media. THP1-




3.3.3 Modulation in NF-κB activation of THP1-Blue cells 
Live ST7-B and ST4-WR1 parasites were then incubated with THP1-Blue 
cells and assayed for SEAP secretion. SEAP activities in culture supernatant 
taken from THP1-Blue cells exposed to parasites of either isolate were 
measured to be markedly lower than background values taken from the 
complete media negative control (ST7-B, p<0.01; ST4-WR1, p<0.01) (figure 
3.3A,B). This suggests that parasites of both isolates significantly reduce 
background NF-κB activation in THP1-blue cells. When incubated 
concurrently with TLR-4 ligand LPS, live parasites of both isolates reduced 
SEAP activity, suggesting a dampening of NF-κB activation. However, only 
ST4-WR1-mediated SEAP activity reduction is significantly lower than that 
observed in the 1µg/ml LPS positive control (p<0.01).  
 
The slight decrease in cell viability previously observed in Fig 3.1A may 
explain in part the reduction in background THP1-Blue NF-κB activation. In a 
setting where THP1-Blue cells were incubated directly with live parasites, live 
Blastocystis may effect changes to SEAP produced from activated THP1-Blue 
cells. To investigate such possible effects by live ST7-B and ST4-WR1 
parasites, cell-free conditioned culture supernatant from THP1-Blue cells that 
had prior exposure to LPS was also incubated with live ST7-B and ST4-WR1 
parasites. SEAP activity in these culture supernatant samples was then 
measured. SEAP activity was found to be decreased in culture supernatant 
samples that were incubated with live ST7-B and ST4-WR1 parasites (Fig 
3.4A). This suggests that live ST7-B and ST4-WR1 parasites were able to 
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inhibit the activity of SEAP produced from activated THP1-Blue cells after 
ligand stimulation. This, taken together with the previously observed slight 
decrease in THP1-Blue cell viability, may explain the observations reported in 
Fig 3.3B.  
 
Cell lysate of both isolates was incubated with THP1-Blue cells and similarly 
assayed for SEAP secretion. Previously observed effects of live parasites on 
THP1-Blue, in the presence or absence of LPS, were not observed with whole 
Blastocystis lysate. Cell lysate of both isolates did not have any significant 
effect on background SEAP activity when compared to the complete media 
negative control (Fig 3.4B). Interestingly, augmentation of SEAP activity in 
the presence of LPS was observed only with ST7-B cell lysate and not ST4-
WR1 cell lysate. This increased SEAP activity was significant for both THP1-
Blue cells pre-treated with ST7-B cell lysate before LPS exposure and cells 
co-cultured with both ST7-B cell lysate and LPS (p<0.05; p<0.01 
respectively) (Fig 3.5A).  
 
In seeking explanation for the various parasite lysate-induced effects on LPS-
mediated NF-κB activation, cell lysate of both isolates was heat-treated at 
95
o
C for 10 minutes before incubating with THP1-Blue cells, in the presence 
or absence of LPS, for 24 hours (Fig 3.5B). THP1-Blue cells did not show 
significantly different levels of SEAP activity when exposed to heated 
Blastocystis cell lysate, compared to the complete media negative control. 
There was also no significant deviation from the previously observed increase 
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in SEAP activity in the presence of LPS and ST7-B cell lysate. Interestingly, 
heat treatment of ST4-WR1 cell lysate was observed to augment SEAP 
activity in the presence of LPS, to levels similar to those observed for heated 
ST7-B cell lysate. 
 
Effects of Blastocystis ST7-B and ST4-WR1 on NF-κB activation triggered by 
other TLR ligands were also investigated. Zymosan, a cell wall preparation 
from the yeast Saccharomyces cerevisiae and purified flagellin from the 
Gram-negative bacteria Salmonella typhimurium were used. THP1-Blue cells 
were incubated with Blastocystis cell lysate, in the presence or absence of a 
specific ligand. While ST7-B cell lysate showed an augmenting effect in LPS-
mediated NF-κB activation, we observed a dose-dependent inhibition in 
zymosan-mediated NF-κB activation by both ST7-B and ST4-WR1 cell lysate 
(p<0.01) (Fig 3.6). However, neither an augmenting nor an inhibiting effect 
was observed from Blastocystis cell lysate of both subtypes on flagellin-
mediated NF-κB activation (Fig 3.7). 
 
3.3.4 Verification of NF-κB-mediated SEAP expression by RT-qPCR 
To verify that observed increase in SEAP activity is attributed to an increase 
in expression of the SEAP gene, reverse transcription real time-PCR was 
carried out to assess expression levels of the SEAP gene in THP1-Blue cells 
after exposure to different experimental conditions (Fig 3.8). Significant 
increase in fold change of SEAP mRNA transcription levels was observed 
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only in THP1-Blue cells co-cultured in the presence of both ST7-B cell lysate 
and LPS (p<0.01). This is consistent with the SEAP enzymatic activity 



















Fig 3.1. Cell viability analysis of THP1-Blue under various experimental 
conditions. (A,B) AnnexinV-FITC PI viability assessment of THP1-Blue 
monocytes after exposure to live parasites. Only live ST7-B induced modest 
but statistically significant levels of apoptosis in THP1-Blue cells. Modest 
increases in necrotic THP1-Blue cells were also observed for all exposures to 
live parasites, with the highest increase observed for ST7-B. (C)  THP1-Blue 
cells were exposed to parasite lysate in ratios described above for 24 hours in 
37
o
C. THP1-Blue cell viability was then assessed by trypan blue counting 
using a hemocytometer. THP1-Blue cells retain high viability after exposure 































Fig 3.2. Responsiveness of THP1-Blue cells to specific TLR ligands of 
interest. (A) THP1-Blue cells were exposed to different TLR ligands for 24 
hours in 37
o
C. NF-κB activation occurs downstream that effects expression of 
SEAP gene and secretion of SEAP into culture supernatant. Absorbance 
readings used as a measure of SEAP activity on substrate medium. THP1-Blue 
cells are sensitive to various TLR ligands and are activated to different degrees 
after ligand exposure. (B) Representative wells showing SEAP activity on 
substrate medium resulting in colorimetric changes in culture supernatant from 
































Fig 3.3. Co-culture experiments of THP1-Blue cells with live Blastocystis. (A) 
THP1-Blue cells were incubated with parasite lysate in the presence or 
absence of LPS. Representative images of colorimetric changes to THP1-Blue 
cell culture supernatant, indicating SEAP activity of substrate medium. (B) 
Inter-isolate variation in live Blastocystis in modulating effects on LPS 
stimulation of THP1-Blue monocytes. Detection of SEAP activity from cell 
culture supernatants of THP1-Blue monocytes incubated with various 
conditions. Live parasites incubated with THP1-Blue cells in numbers 
corresponding to ratio of 1 THP1-Blue cell to 10 parasites (1-10), or 1 THP1-
Blue cell to 20 parasites (1-20).  Live ST4-WR1 and not ST7-B significantly 
dampens LPS-mediated NF-κB activation in THP1-Blue monocytes. Live 
parasites of both isolates also significantly reduce background absorbance. 3 
independent experiments were conducted. 
ST7-B lysate 
ST7-B lysate + LPS 
ST4-WR1 lysate 

















Fig 3.4. Direct effects of live parasites or parasite lysate on SEAP activity. (A) 
THP1-Blue cells were incubated with 1µg/ml LPS for 24 hours in 37
o
C. SEAP 
activity in culture supernatant was measured after 24 hour incubation (black 
bar). Culture supernatant was incubated with live parasites in ratios of 1 
THP1-Blue cell : 10 or 20 ST7-B or ST4-WR1 parasites for another 24 hours 
in 37
o
C. SEAP activity remains high after second 24 hour incubation. SEAP 
activity was dampened back to background levels (white bar) in the presence 
of live parasites. Experiment was conducted twice. (B) THP1-Blue cells were 
exposed to LPS overnight. Culture supernatant from LPS-conditioned THP1-
Blue cells was then exposed to parasite lysate of either isolate and at various 
ratios. Parasite lysate does not dampen SEAP activity of substrate medium. 
Culture supernatant (CM) from unstimulated THP1-Blue cells were used for 
controls. Note that THP1-Blue culture media (CM) and parasite lysate alone 
do not show non-specific phosphate activity on substrate medium. Experiment 
was conducted twice. O/N, overnight incubation; 1:10, 1 THP1-Blue to 10 

























Fig 3.5. Blastocystis lysate effects on lipopolysaccharide (LPS) stimulation of 
THP1-Blue monocytes. (A) Detection of SEAP activity from cell culture 
supernatants of THP1-Blue monocytes incubated with various conditions. 
Blastocystis total cell lysate incubated with THP1-Blue cells at amounts 
corresponding to ratio of 1 monocyte to 10 parasites. Blastocystis ST7-B, not 
ST4-WR1, significantly augments LPS-induced activation of THP1-Blue 
monocytes, as observed in the increased SEAP activity. (B) Heat-inactivated 
lysate of both ST7-B and ST4-WR1 shows augmenting effect on LPS-induced 
THP1-Blue activation.  **, p < 0.01; *, p < 0.05, when analyzed against 























Fig 3.6. Blastocystis lysate effects on zymosan (ZG) stimulation of THP1-Blue 
monocytes. Detection of SEAP activity from cell culture supernatants of 
THP1-Blue monocytes incubated with various conditions. A, B. Both 
Blastocystis ST7-B and ST4-WR1 significantly inhibits ZG-induced activation 
of THP1-Blue monocytes, as observed in the decrease in SEAP activity. 
Parasite lysate was added to THP1-Blue cells in terms of amounts of lysate 
prepared from 1 million (mil), 5 million, or 10 million parasites per ml. 
Inhibition observed to be in negative correlation with parasite lysate 
concentration, with significance observed from 5 × 10
6
 ST7-B/ml onward. **, 
p < 0.01, when analyzed against 5µg/ml ZG positive control. 3 independent 



















Fig. 3.7. Blastocystis lysate effects on flagellin (fla) stimulation of THP1-Blue 
monocytes. Detection of SEAP activity from cell culture supernatants of 
THP1-Blue monocytes incubated with various conditions. Parasite lysate was 
added to THP1-Blue cells at amounts that correspond to a ratio of 1 THP1-
Blue cell to 10 parasites. Both Blastocystis ST7-B and ST4-WR1 does not 
significantly modulate fla-induced activation of THP1-Blue monocytes. 3 














Fig 3.8. RT-qPCR analysis of SEAP gene expression in THP1-Blue cells. 
Significant increase in fold change of SEAP gene expression observed only in 
THP1-Blue cells co-cultured with ST7-B cell lysate and LPS. **, p < 0.01, 
when analyzed against 1µg/ml LPS positive control. 3 independent 






To date, there has been no focused investigation on Blastocystis spp. and 
TLRs. Insights into interactions between this enteric parasite and the TLR 
family of PRRs are likely to provide more in-depth characterization of the 
pathogenicity of Blastocystis spp, given the high prevalence of the parasite in 
the global human population, the gastrointestinal symptoms associated with it 
and the role of TLRs in regulating gut immune homeostasis and recognition of 
luminal pathogens to initiate controlled immune responses
108
. In this chapter, 
the THP1-Blue human monocytic cell line was used to investigate 
Blastocystis-host interactions, specifically in the context of TLR and NF-κB 
activation. This cell line serves as an appropriate surrogate reporter model for 
experiments to determine if Blastocystis spp. activates any TLRs and if it 
possesses any modulating effects on the activation of certain TLRs by their 
specific ligands. 
 
Although THP1-Blue naturally expresses all TLRs known to be actively 
present in human cells, we focused on the three that are relevant for the 







, has been shown to be directly involved in the 
maintenance of intestinal homeostasis
111
 and intestinal epithelial barrier 
integrity
112
. TLR-4 naturally binds to bacterial LPS and is linked to gut 
inflammation and inflammatory bowel diseases like ulcerative colitis
113,114
. 
The colon is the main site of expression for TLR-5
115
, which binds to flagellin 
of several bacterial species
116
. TLR-2, -4 and -5 have been shown to be 
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expressed on both apical and basolateral sides of the colonic epithelium, 




THP1-Blue cells were incubated with live parasites or parasite components, 
with or without ligands for TLR-2, -4 and -5. In experiments with parasite 
lysate, Blastocystis spp. did not significantly induce NF-κB activation in 
THP1-Blue cells, as shown by the consistent lack of significant increase in 
SEAP activity in the culture supernatant following exposure to parasite lysate. 
SEAP activity was increased only in the presence of TLR ligands like LPS. 
This lack of significant SEAP activity by parasite lysate alone was confirmed 
by RT-qPCR that SEAP expression levels were indeed close to background 
levels in THP1-Blue cells exposed to parasite lysate. Taken together, this 
suggests for the first time that Blastocystis spp. lysate is unable to activate 
TLRs and downstream signalling cascades leading to NF-κB activation. 
Previously, there had been no published characterizations on interactions 
between Blastocystis spp. and TLRs. Most known ligands of TLRs are either 
of bacterial or viral origin, with some protozoan parasites like Typanosoma 





Recently, cysteine proteases of Blastocystis ST4-WR1 has been found to 
mediate IL-8 secretion from human colonic epithelial T84 cells in an NF-κB-
dependent manner
80
. Taken together, this suggests that the NF-κB-dependent 
expression of IL-8 in T84 colonic epithelial cells may be mediated by 
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mechanisms independent of TLRs. Indeed, bacterial pathogens have been 
observed to induce inflammatory responses via receptors that are not TLRs. 
For instance, the Serratia marcesens-derived protease serralysin induces host 
inflammatory responses through protease-activated receptor 2 (PAR-2), 
activating NF-κB and upregulating IL-8 expression118. More recently, the 
same group characterized a novel secreted protease from Pseudomonas 
aeruginosa and found it capable of activating NF-κB through PAR-1, -2 or -
4
119
. In addition to PAR-mediated mechanisms, cyclooxygenase-2-mediated 
prostaglandin E2-dependent modulation of IL-8 production and neutrophil 
infiltration has been observed in a human fetal intestinal xenograft mouse 
model used to study Entamoeba histolytica infection
120
. Also, toxins from 
Clostridium difficile are observed to target host Rho GTPases and lead to the 
activation of mitogen-activated protein kinase (MAPK)-activated protein 
kinase, which contributes to Clostridium difficile-associated epithelial injury 
and intestinal inflammation
121
. Given the growing complexity in intracellular 
interactions and signal transduction pathways that drive infection-associated 
host inflammation, further characterization would have to be carried out to 
delineate the specific mechanisms associated with Blastocystis-induced 
intestinal inflammatory response. 
 
In experiments between THP1-Blue cells and live Blastocystis spp., we 
observed that only live ST4-WR1, and not ST7-B parasites, significantly 
dampened LPS-mediated NF-κB activation when THP1-Blue cells were co-
cultured with both live ST4-WR1 parasites and LPS. Although this suggests 
that live ST4-WR1 parasites may modulate immune responses mediated by 
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bacterial components, it was then verified that live ST4-WR1 parasites also 
significantly dampen SEAP signals from THP1-Blue-free culture supernatant 
collected after LPS pre-treatment of THP1-Blue cells. Hence, the decrease in 
SEAP activity effected by live parasites does not necessarily reflect a direct 
inhibition of LPS-mediated NF-κB activation and a bonafide immuno-
modulatory effect of Blastocystis spp. on host immunity, but rather a 
limitation of the THP1-Blue cell model. Verification through techniques like 
RT-qPCR analysis of the SEAP reporter gene from THP1-Blue cells after 
exposure to live parasites and parasite lysate will more adequately determine if 
live Blastocystis has any modulating effect on SEAP expression and if such 
modulating effects on SEAP expression is consistent with data on SEAP 
activity. Interestingly, we observed that both live ST4-WR1 and ST7-B 
parasites were able to induce significantly higher up-regulation of the SEAP 
gene when compared to LPS-mediated NF-κB activation and SEAP up-
regulation. This brings clarity to earlier deductions of apparent dampening of 
LPS-mediated NF-κB activation from observations of decrease in SEAP 
activity. Nonetheless, Blastocystis spp.-mediated modulation of host immune 
responses has been observed in colonic epithelial cells, in which IL-8 
production was observed to be reduced when Escherichia coli LPS was co-
cultured with the HT-29 colonic epithelial cells along with live Blastocystis 
spp. ST1-NandII parasites
122
. However, tests to directly assess NF-κB 
activation in human cells after exposure to live parasites, such as measurement 
of IκB phosphorylation, should be carried out next for definitive verification 




The significant and direct inhibition of SEAP activity by live parasites 
presented a limitation in this cell model when exploring TLR stimulation and 
NF-κB activation in the context of challenge with live Blastocystis spp. 
However, Blastocystis spp. cell lysate was not found to inhibit SEAP activity. 
Hence, in addition to live parasites, we also included in this chapter, testing for 
NF-κB activation in THP1-Blue cells using parasite cell lysate from both ST7-
B and ST4-WR1 isolates. Interestingly, previous observations made in 
experiments exposing THP1-Blue cells to live parasites, in the presence or 
absence of LPS, were not made again in similar set-ups involving Blastocystis 
spp. cell lysate. This suggests that the previously observed ST4-WR1 
dampening of LPS-mediated NF-κB activation may be mediated only by live 
ST4-WR1 parasites. Moreover, ST7-B cell lysate and not ST4-WR1 
unexpectedly showed a significant augmenting effect on LPS-mediated THP1-
Blue NF-κB activation observed as increased SEAP activity as compared to 
LPS positive control. This augmenting effect in SEAP activity was not 
observed in experiments involving live ST7-B parasites and as with previous 
SEAP activity experiments described above involving live parasites, further 
verification via RT-qPCR must be conducted to determine if SEAP expression 
is modulated by Blastocystis, with subsequent comparison of SEAP expression 
data to observations made of SEAP activity. In view of the lack of such 
verification, it is premature to hypothesize that this SEAP activity 
augmentation is mediated by intracellular parasite factors that are not secreted 
by live parasites and become accessible to host cells when parasite cells 




Lysis of Blastocystis spp. may be mediated physiologically by a variety of 
different factors. In the human gut, Blastocystis spp. is exposed to a gamut of 
host responses that would effect parasite cell lysis. It was reported recently 
that ST4-WR1 and ST7-B are sensitive to nitrosative stress, exhibiting 
increased apoptotic and necrotic features upon exposure to nitric oxide
70
. 
Although no study has yet been done on the effects of gut anti-microbial 
peptides on Blastocystis spp., the effectiveness of synthetic antimicrobial 
peptides, analogous to naturally produced Xenopus laevis skin magainin 
peptides had been demonstrated against Blastocystis spp., with total cell 
destruction and leakage of cellular contents
123
. LL-37, a cathelicidin 
antimicrobial peptide commonly expressed in the human gut, shares similar 
structural features with magainin, in that the peptide comprises largely of 
linear cationic α-helices. A recent study showed that another enteric protozoan 
parasite Entamoeba histolytica increased LL-37 expression from colonic 
epithelial cells and exhibits resistance against LL-37-mediated killing though 
parasite protease-mediated degradation of LL-37
124
. It remains to be seen if 
Blastocystis spp. is vulnerable to antimicrobial action of LL-37 and other 
human antimicrobial peptides like defensins. Considering these examples of 
innate host responses against gut microbes, we hypothesize that host response-
mediated cell lysis does occur in Blastocystis spp., which gives rise to parasite 
cell lysate that would contribute to the observed effects to TLR activation in 
this chapter.  
 
Interestingly, there is an increasing body of evidence that suggest TLR4-





elucidating these novel mechanisms propose that LPS may be delivered into 
the cytoplasm by cholera toxin B, which in turn activates caspase-11 and 
trigger IL-1β production125. IL-1β is a pro-inflammatory cytokine and has 
been well-established to be one of several potent inducers that activate NF-
κB126. However, it is worth noting with caution that the putative internal LPS 
sensor that is integral to this TLR4-independent mechanism has yet to be 
identified. Future investigations would also have to be made to determine if 
elements of Blastocystis spp. cell lysate, if any, are also able to transport LPS 
across the host cell membrane into the cytoplasm. As such, this remains, at 
best, a preliminary possibility to explain the augmentation effect observed for 
LPS-induced NF-κB activation and increased SEAP activity.   
 
The objective of the heat-treated parasite lysate experiments was primarily to 
begin exploring mechanics behind Blastocystis spp.-mediated modulation of 
ligand-specific TLR stimulation and NF-κB activation. ST7-B-mediated 
augmentation of LPS-induced TLR-4 and NF-κB activation was not affected 
by the heat treatment. Interestingly, a similar augmentation effect of LPS-
induced TLR-4 and NF-κB activation became present in ST4-WR1 lysate after 
heat treatment. This suggests firstly that the components responsible for the 
augmentation effect in ST7-B lysate were likely to be heat stable; secondly 
that the counterpart components for the augmentation effect in ST4-WR1 
lysate only became active after heat-labile components, possibly proteins, had 
been deactivated by heat. We hypothesize that denaturation of these heat-
labile components in cell lysate by heating may have altered their structural 
conformation of these components and rendered them structurally accessible 
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for ligation to other accessory receptors such as scavenger receptors, which 
may contribute to augmentation of  NF-κB activation. To the best of our 
ability, we have not found in literature any similar observations of a gain in 
augmentation of host cell NF-κB activation by microbial components after 
heat treatment.  
 
Taking a broader perspective, findings from recent studies have suggested that 
a basal activation of TLR-4 in healthy mucosa by selective commensal 
microbes and factors derived from these organisms confer protection against 
injury
111,127
 and dampens immunopathological responses against food 
allergens
128,129
. Puthia et al. (2008) showed that ST4-WR1 induced IL-8 
production from T84, a human colonic epithelial cell line in an NF-κB-
dependent manner
80
. In another study involving solubilized antigen of 
Blastocystis cultures axenized from both symptomatic and asymptomatic 
patients, only solubilized antigen from a symptomatic source significantly up-
regulated NF-κB expression while solubilized antigen from an asymptomatic 
source did not have a significant effect on NF-κB expression130. It should be 
noted that the authors of this study did not genotype the patient-derived axenic 
Blastocystis cultures into defined subtypes. This makes it difficult to correlate 
their findings to other studies using Blastocystis of defined subtypes. In 
addition, this study investigated NF-κB gene expression and not activation, 





We hypothesize that given the genetic diversity of Blastocystis spp., 
pathogenesis of this parasite may not simply involve directly pathogenic 
isolates that alone are capable of the onset of gastrointestinal symptoms. Some 
subtypes of the parasite modulate host immunity by up-regulating NF-κB gene 
expression, while other subtypes, like ST4 and ST7, augment NF-κB 
activation in the presence of known pathogen factors like LPS. More 
specifically, parasite subtypes capable of modulating LPS-mediated TLR-4 
activation in a positive manner may disrupt this balance of basal TLR-4-
dependent signals that contribute towards gut homeostasis, allowing a 
bystander inflammation effect. Up-regulation of NF-κB expression has only so 
far begun to show an emerging association with gastrointestinal symptoms. In 
the presence of pathogen factors, augmentation of NF-κB activation by 
Blastocystis may induce a state of inflammation that is more pronounced 
compared to the absence of Blastocystis. This may disrupt gut immune 
homeostasis, leading to a greater degree of cellular damage to the gut mucosa 
of the host and also possibly dysbiosis in gut microbiota, bringing about 
further impairment to gut health and function. 
 
In addition, TLR-4 has been found to be more highly expressed in intestinal 
epithelial cells and lamina propria immune cells of inflammatory bowel 
disease (IBD) patients 
108,115,131
. Moreover, an emerging but weak association 





. Taken together with previously 
reported findings of upregulation of pro-inflammatory cytokine gene 
expression in experimentally infected rats
35
; and increased IL-8 production 
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from human colonic epithelial cells
80
, chronic inflammation commonly 
associated with IBS and IBD may be a result of complex interactions 
involving LPS and parasite components, activating TLR-4 and other receptors 
in a concomitant manner.  
 
This augmenting effect from ST7-B cell lysate for LPS-mediated THP1-Blue 
NF-κB activation was not observed in the activation of other TLRs by their 
corresponding ligands. In contrast, both ST4-WR1 and ST7-B cell lysate 
showed an inhibitory effect in zymosan-mediated NF-κB activation in THP1-
Blue cells, reflected in the decrease in SEAP activity in THP1-Blue culture 
supernatant in a dose-dependent manner, after exposure to Blastocystis spp. 
cell lysate of different concentrations. TLR-2 has been implicated to not only 
have an immune-sensing role against pathogenic bacterial cell wall 
component, but also functions to enhance ZO-1-associated intestinal epithelial 
barrier integrity via protein kinase C
112
. Therefore, it is possible that in the 
event of a Blastocystis spp. infection with subtypes that bring about 
dysregulation of TLR-2 signalling, this effect on host cells may be an 





The disruption of intestinal epithelial barrier integrity by Blastocystis spp. may 
provide TLRs localized beneath the apical surface of the intestinal epithelium 
access to luminal pathogen-derived ligands. For instance, TLR-5 is the 
predominant receptor for bacterial flagellin
116





. This implicates an accessory role in Blastocystis spp. 
towards bacterial induction of intestinal inflammation, which contributes to an 
emerging picture of the direct and indirect participation of Blastocystis spp. in 
the disruption of intestinal homeostasis. 
 
In conclusion, our data shows for the first time that Blastocystis exhibits 
pleiotropic effects in the modulation of TLR activation by specific ligands, 
namely zymosan, LPS and flagellin for TLR-2, TLR-4 and TLR-5 
respectively. However, it should be noted that the scope of this chapter has 
been confined to 2 isolates of Blastocystis spp., which in turn represent only 2 
of 14 subtypes identified to date, 9 of which have been identified in 
humans
102
. Blastocystis spp. is known to be genetically diverse
102
 and along 
with other factors like the lack of standardization across studies and diagnostic 
techniques have led to conflicting reports in support of a role for Blastocystis 
spp. pathogenicity
7
. Indeed, it has recently been demonstrated that high 
genetic diversity also exists within a subtype
134
. Future experiments should 
focus on investigations that involve more isolates to represent more subtypes 
that are clinically relevant to humans; and bringing the study of Blastocystis 
spp.-TLR interactions to the intestinal mucosal context. Through this work, 
efforts continue to delineate mechanisms that underpin symptoms associated 
with Blastocystis spp. infections and to provide more accurate insights into the 
pathogenesis of this highly prevalent enteric parasite and how it interacts with 
gut mucosa. In turn, this information would provide clinicians with a more 











EFFECTS OF BLASTOCYSTIS SPP. ON 





In the previous chapter, we observed that neither live Blastocystis spp. nor 
parasite lysate activated TLRs. Interestingly, although Blastocystis spp. did not 
directly induce TLR activation and downstream NF-κB signalling, the parasite 
was shown to have modulating effects on TLR signalling by specific ligands. 
 
It is known that Blastocystis spp. colonises on epithelial mucosa of the large 
intestine. Recent findings in literature have reported effects of Blastocystis 
spp. on colonic epithelial cell viability and tight junction integrity. Wu et al. 
(2014) reported that Blastocystis ST7 but not ST4 significantly induced 
apoptosis in the human colonic epithelial cell line Caco-2, activating caspases 
-3 and -9 but not -8
106
. ST7 was also observed to induce changes in epithelial 
resistance, permeability, and relocalization of the tight junction protein ZO-
1
104
. The same group also recently reported intra-subtype variations in the 
degradation of ZO-1 and occluding tight junction proteins, with different 
isolates of ST7 showing dissimilar degrees of tight junction protein 
disruption6. In contrast, ST4 was not observed to have a significant effect on 
tight junction protein integrity or permeability of intestinal monolayers.  
 
In both studies, Caco-2 enterocytes were exposed to the same high parasite 
burden in terms of the number of live parasites or concentration of parasite 
lysate. In Chapter 2, I discussed the differences in sizes and total protein 
content of ST4-WR1 and ST7-B parasites. I hypothesize that such differences 
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may explain, at least in part, a growing body of observations that these 2 
Blastocystis strains give rise to different effects on host cells, such as the ones 
highlighted above. Hence, I set out to verify previously observed changes in 
permeability of Caco-2 monolayers and to investigate permeability changes in 
a more nuanced context of having ST4 and ST7 parasite burdens normalized 
to previously established measurements of total protein content from lysed 
parasites. 
 
In addition, one study demonstrated through mouse models and in vitro studies 
that isolates from Blastocystis spp. subtypes 4 and 7 are capable of inducing 
abundant expression of pro-inflammatory cytokines IL-1β, IL-6 and TNF-α 
via activation of the MAP kinases ERK and p38. The same study also found 
for the first time that ST7-B serine proteases play a major role in the activation 





Dendritic cells (DCs) are professional antigen presenting cells which capture 
antigens by phagocytosis and pinocytosis and process them into peptides for 
presentation on MHC proteins. They are abundant at mucosal surfaces 
throughout the body, such as pulmonary and enteric surfaces
135
. In the context 
of intestinal mucosa, DCs are found in Peyer’s patches at the ileum, 
surrounding mesenteric lymph nodes and the lamina propria along small and 
large intestinal epithelia
136
. They serve the important role of immune 
surveillance of luminal contents for pathogens and pathogenic factors and 
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mount appropriate responses in the presence of an infection. As DCs are the 
dominant antigen presenting cell to naïve CD4
+
 T cells, they are the mediators 
of a transition from innate to adaptive immunity in the development and 
maturing of an immune response against a pathogen. 
 
Currently, no work has been done to investigate interactions between 
Blastocystis spp. and dendritic cells. In this study, we employ an established 
and widely used class of dendritic cell for host-pathogen interaction studies, 
the human peripheral blood monocyte-derived dendritic cells (MoDCs), to 
investigate Blastocystis effects on dendritic cell biology and function. Through 
this study, we aim to improve understanding of mechanisms within a 




4.2 MATERIALS AND METHODS 
4.2.1 Caco-2 human colonic epithelial cell culture  
The culturing protocol was adapted from ATCC. All transwell experiments 
were performed using a transformed human intestinal epithelial cell line, 
Caco-2 (ATCC). The Caco-2 cell stock was maintained in T-75 flasks (Iwaki) 
in a humidified 37
o
C incubator with 5% CO2. Passages 3 to 25 were used for 
all experiments. The growth medium in T-75 flasks for the first passaging 
after thawing of frozen cells consisted of Dulbecco’s modified Eagle’s 
medium (DMEM) (Sigma D1152) supplemented with 1.0mM sodium 
pyruvate (Sigma), 0.1mM non-essential amino acids (Gibco), 100 units of 
penicillin and 100µg streptomycin (Gibco) and 20% heat-inactivated foetal 
bovine serum (Gibco). Serum levels were reduced to 10% for subsequent 
passages. Cells were subcultured every 4 days at a seeding intensity of 2 × 10
6
 
cells per flask. The culture medium was replenished every two to three days. 
Cells were trypsinised upon reaching confluence with 0.25% trypsin-EDTA 
(Gibco) and cell viability was analysed using the trypan blue exclusion assay. 
 
4.2.2   Transepithelial electrical resistance (TEER) measurement 
Caco-2 cells were seeded into transwell cell culture inserts with polyethylene 
terephthalate filters of 3µm pore size (Millipore), at a seeding density of 5×10
4
 
cells per insert. Seeded inserts were housed in 24 well tissue culture plates in 
culture conditions described above. Complete media was changed every 2-3 
days until confluency (~day 21) and TEER readings exceed 1500Ω/cm2. 
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Extraction of cells from transwell inserts by trypsinisation, following by 
Trypan Blue counting yielded consistent counts of 1 × 10
6
 Caco-2 cells per 
monolayer. Cells were serum starved in serum-free media overnight before co-
culture with live parasites or parasite lysate for 24 hours. TEER was then 
measured using the EVOM2 epithelial voltohmmeter (World Precision 
Instruments).  
 
4.2.3 Epithelial permeability assessment by FITC-dextran flux     
Experimental protocol was adapted from a previously optimised methodology 
utilised in a published study
105
. Caco-2 monolayers were prepared as 
described above for TEER experiments, along with similar serum starvation 
synchronisation prior to exposure to Blastocystis. After parasite exposure, both 
apical and basolateral compartments of the transwell insert system were 
washed twice with warmed Hank’s balanced salt solution (HBSS) (Life 
Technologies), followed by addition of 400 ml of warm HBSS at the 
basolateral compartment and 200 ml of 100 mg/ml FITC-conjugated dextran 
4000 solution in HBSS to the apical compartment. After 3 hours, 300 ml of 
basolateral HBSS was transferred to a 96-well microplate (Grenier) to assess 
amount of FITC-dextran flux across the monolayers. Fluorescence was 
measured using a Tecan Infinite M200 ELISA reader (Tecan) at excitation and 





4.2.4  PBMC isolation from whole blood 
All human blood specimens were obtained under informed consent from 
healthy volunteers, under approval by the National University of Singapore 
Institutional Review Board (NUS-IRB ref code: 05-110; approval number: 
NUS-173). Human peripheral blood mononuclear cells (PBMCs) were 
isolated using density gradient centrifugation with Ficoll-Paque PLUS density 
gradient separation medium (GE Healthcare). PBMC fraction was then 
removed from the density gradient into fresh centrifuge tubes and washed 
thrice in PBS with 0.4% sodium citrate. Washed PBMCs were then counted 
using a haemocytometer. 
 
4.2.5  Magnetic bead selection for monocytes and CD4
+
 T cells 
PBMCs were enriched for CD14
+
 monocytes by positive selection using 
magnetic cell sorting (MACS) with anti-CD14 labelled microbeads 
respectively. (Miltenyi Biotec). Naive CD4
+
 T cells were similarly enriched 
from PBMCs by positive selection using MACS (Miltenyi Biotec), using anti-
CD4 labelled microbeads. PBMCs were incubated with the appropriate 
microbeads as per manufacturer’s recommendations before undergoing 
positive selection via MACS.       
 
4.2.6  Differentiation of CD14
+
 monocytes into MoDCs 
Isolated monocytes were cultured incubated at a humidified 37
o
C incubator 
with 5% CO2 for 7 days in DMEM (Hyclone) supplemented with 10% heat-
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inactivated human serum AB (PAA Laboratories), 500ng/ml granulocyte-
macrophage colony-stimulating factor (GMCSF) (Miltenyi Biotec, Singapore) 
and 500ng/ml interleukin-4 (IL-4) (Miltenyi Biotec, Singapore) for 
differentiation into immature MoDCs. 
 
4.2.7  MoDC surface marker analysis via flow cytometry 
Immature MoDCs were collected after exposure to either live parasites or 
parasite lysate for 24hr, washed twice in sterile PBS and analysed by flow 
cytometry for activation and maturation surface markers CD80 and CD83 
respectively (BD Biosciences, Singapore). In conditions involving direct co-
culture with live parasites, MoDCs were selected by size gating and dendritic 
cell marker CD11c
+
 gating. 1µg/ml lipopolysaccharide (LPS) with and 
without 40ng/ml recombinant human TNF-α (PeproTech) were used as 
positive controls for activation and maturation of MoDCs. 
 
4.2.8  MoDC uptake of CFSE-labelled Blastocystis 
For analysis by confocal microscopy, immature MoDCs were co-cultured 
directly with live CFSE-labelled parasites for 24hr before being seeded onto 
poly-L-lysine glass coverslips overnight. Adhered MoDCs were then fixed in 
1:1 methanol-acetone fixative for 30min at 4
o
C. Fixed MoDCs were rinsed 
with PBS and then blocked with 1% BSA for 1hr at room temperature. After 
blocking, MoDCs were stained with monoclonal mouse anti-human HLA-
ABC clone W6/32 primary antibody (Dako) and Alexa Fluor 647-conjugated 
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polyclonal goat anti-mouse antibody was used as the secondary antibody. 
Washes were carried out by rinsing with PBS and nuclear DNA was stained 
with 10µg/ml Hoescht 33342 (Life Technologies) for 20min at room 
temperature before the last 2 washes. Stained MoDCs were inversed and 
mounted onto clean glass slides with VECTASHIELD
®
 fluorescence 
mounting medium (Vector Laboratories) before observation under an 
Olympus FluoView FV1000 confocal microscope (Olympus, Japan). FV10-
ASW 2.0a (Olympus, Japan) and ImageJ (NIH) software was used for post-
capture image analysis. For quantitative analysis of CFSE uptake by flow 
cytometry, immature MoDCs were co-cultured directly with live CFSE-
labelled parasites for 4 hours at either 4°C or 37°C. Flow cytometry was used 
for quantitative analysis of uptake of CFSE-labelled parasites by MoDCs, with 
phycoerythrin (PE)-monoclonal antibody staining of human HLA-A,B,C 
(Biolegend) used as selection gating for human MoDCs during flow 
cytometric analysis for CFSE fluorescence. 
 
4.2.9 Inhibition of phagocytosis in MoDCs 
A similar methodology as the MoDC surface marker flow cytometric analysis 
described in 4.2.7 was used, with some modifications. Briefly, immature 
MoDCs were conditioned in complete media containing 1µg/ml cytochalasin-
D (Sigma-Aldrich) for 1 hour before exposure to live Blastocystis spp. for an 
incubation period of 24 hours. MoDCs were then washed twice in sterile PBS 




4.2.10  Cytokine/chemokine expression analysis via ELISA   
Immature MoDCs were co-cultured with live parasites or parasite lysate for 
24hr in culture conditions. Culture supernatant was collected and immediately 
stored at -80
o
C before use. TNF-α levels in MoDC culture supernatant were 
quantified using the Human TNF-α Standard ELISA Development Kit 
(Peprotech), according to manufacturer’s recommendations. 1µg/ml LPS was 
used as a positive control for secretion of TNF-α from MoDCs. Similar 




 T cell proliferation assay 
 Proliferation of CD4
+
 T cells was assessed by allogeneic reactivity 
with MoDCs in a mixed lymphocyte reaction (MLR) assay and by mitogenic 
induction of T-lymphocyte cell division, followed by thymidine incorporation 
assay. After exposure to Blastocystis, MoDCs were washed with PBS and co-
cultured with naïve CD4
+
 T cells for 7 days at a ratio of 1 MoDC to 10 T cells 
in DMEM (Gibco), supplemented with 10% heat inactivated AB serum (PAA 
Laboratories) in 24-well culture plates (NUNC) in a humidified 37
o
C 
incubator with 5% CO2. As a basal control, naïve CD4
+
 T cells were cultured 
with unstimulated MoDCs. In separate experiments, naïve CD4
+
 T cells alone 
were also incubated with varying Blastocystis doses, in the presence or 
absence of the mitogen phytohaemagglutinin (PHA) for 48 hours. After 
incubation, both T cells from MoDC co-cultures and PHA-conditioned T cells 
were pulsed with tritium-thymidine for thymidine chase overnight. DNA was 
then harvested onto a filter plate, dried and covered with scintillation liquid 
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before measurement of radiation counts in a TopCount microplate scintillation 
counter (Perkin Elmer). 
   
4.2.12  Statistical analysis 
Student’s t-test was used to ascertain statistical significance of all data. All 
experiments were conducted in triplicate and at least 2 independent 




4.3.1 Effects on the colonic epithelium 
Permeability of Caco-2 monolayers was assessed by measurement of TEER 
across monolayers before and after exposure to Blastocystis spp. Previous 
studies have demonstrated, by using much higher doses, that Blastocystis ST7-
B increases Caco-2 colonic epithelial permeability
104,105
. By using more 
conservative ST7-B parasite doses titrated across a range of 1 host cell to 1-10 
parasites, against the same host cell line and through similar exposure 
durations, we showed that the exposure ratio of 1 Caco-2 cell to 10 parasites 
was the lowest parasite dose to induce significant TEER drop across Caco-2 
monolayers, which corresponds to a significant increase in monolayer 
permeability (Figure 4.1A). Caco-2 epithelial permeability was also assessed 
by measuring FITC-dextran flux across monolayers in transwell inserts, from 
apical to basolateral compartments. At the same exposure ratio of 1 Caco-2 
cell to 10 parasites, significantly higher fluorescence was observed in 
supernatant samples from basolateral compartments, indicating increased 
FITC-dextran flux across monolayers exposed to ST7-B (Figure 4.1B).   
 
In experiments comparing isolates from different subtypes, we observed that 
when Caco-2 monolayers were exposed to similar numbers of live ST4-WR1 
and ST7-B parasites or parasite lysate at the ratio of 1 Caco-2 cell to 10 live 
parasites, only ST7-B live parasites and parasite lysate induced significant 
decrease in TEER, indicating an increase in epithelial permeability (Figure 
4.2). In addition, the increase in permeability mediated by live ST7-B parasites 
was higher than that from ST7-B lysate. Both live ST4-WR1 parasites and 
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parasite lysate did not induce a significant increase in Caco-2 epithelial 
permeability. However, when ST4-WR1 doses were adjusted to match ST7-B 
doses by intracellular protein content, as previously outlined in Chapter 2, 
both live ST4-WR1 and ST4-WR1 lysate of adjusted doses induced significant 
decrease in TEER to similar degrees to those observed from ST7-B (Figure 
4.2). 
 
4.3.2  Effects on MoDCs 
Previous reports of Blastocystis-mediated epithelial permeability increase only 
studied the effects of isolates from 1 subtype
105
, or did not factor inter-subtype 
differences like cell size and protein content disparities into exposure ratios
106
. 
Using exposure ratios for ST4-WR1 and ST7-B equilibrated in Chapter 1, we 
investigated the effects of live Blastocystis spp. parasites or parasite lysate on 
MoDC activation and activation, in the presence or absence of an epithelial 
barrier.   
 
4.3.2.1  MoDC activation and function 
 In this study, immature MoDCs differentiated from primary monocytes were 
exposed to live parasites or parasite lysate for 24hr before flow cytometric 
analysis for activation and maturation surface marker phenotypes. MoDCs 
were exposed to live parasites in either a direct or indirect manner (Figure 
4.3). The indirect configuration consisted of parasites being separated from 
MoDCs either by a 0.4µm transwell insert, or by a confluent Caco-2 
monolayer cultured in a 3 µm transwell insert. For the first time, MoDC 
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activation and maturation, marked by CD80 and CD83 up-regulation 
respectively, was observed only in MoDCs directly cultured with live ST7-B 
parasites (Figure 4.4A, B). 
  
In direct exposure experiments to compare between the effect of small vs large 
parasites on MoDC activation, only both large and small ST7-B parasites were 
able to significantly up-regulate CD83 on MoDCs, and to similar levels 
(Figure 4.5). When interaction ratios of both large and small parasites of ST4-
WR1 and ST7-B with MoDCs were normalized based on protein content 
(ST4-WR1: 1 MoDC to 50 parasites; ST7-B: 1 MoDC to 10 parasites), no 
significant CD83 up-regulation was observed in MoDCs exposed to ST4-WR1 
(Figure 4.5). Interestingly, when live ST-7 parasites were cultured with 
MoDCs in the presence of LPS, CD80 up-regulation was significantly higher 
than levels observed in the positive control of MoDCs treated with LPS 
(Figure 4.6). We also observed significant augmentation in the percentage of 
activated, mature MoDCs cultured with live ST7-B, when compared to the 
LPS positive control (p<0.05). The percentages of activated, mature MoDCs 
exposed to live ST7-B alone or to ST7-B total cell lysate (TCL) were not 
found to differ significantly from that of the LPS positive control (Figure 4.7). 
 
After observing that MoDCs were matured and activated only through direct 
contact with live Blastocystis spp. parasites, and that different configurations 
of indirect exposure to parasites, simply via a 0.4µm transwell filter or a 
confluent Caco-2 monolayer failed to induce the similarly significant levels of 
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MoDC maturation and activation, we then asked whether the observed MoDC 
maturation and activation might be mediated by direct phagocytosis of the live 
parasites. To date, host cell phagocytosis of Blastocystis spp. has not been 
reported in literature.  
 
To this end, live Blastocystis spp. parasites were stained with the viability dye 
CFSE before being cultured directly with immature MoDCs for 24hr. After 
co-culture, MoDCs were adhered onto glass coverslips and imaged by 
confocal microscopy. We observed a positive green fluorescence signal only 
from MoDCs that had been cultured with CFSE-labelled ST7-B parasites 
(Figure 4.8). Z stacking analysis further indicates that the CFSE labelled 
parasites were within MoDCs, from the observation of green fluorescence 
being localised inside the cell boundary of MoDCs, which was stained red 
with anti-MHC-I antibodies (Figure 4.8). This suggests for the first time that 
MoDCs are capable of ingesting live Blastocystis parasites and provides a 
possible explanation behind MoDC activation and maturation only after direct 
contact with live Blastocystis spp. ST7-B parasites.   
 
To validate this qualitative observation of uptake of CFSE-labelled parasites 
by MoDCs, the uptake experiments were repeated, with some modifications to 
the experimental methodology. Incubation times were reduced to 4 hours and 
incubation was carried out at either 4°C or 37°C. Flow cytometry was used for 
more quantitative analysis. CFSE uptake of MODCs exposed to CFSE-
labelled ST7-B in 4°C was over 3-fold lower than that of MoDCs similarly 
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exposed to ST7-B at 37°C, while CFSE fluorescence in MoDCs exposed to 
labelled ST4-WR1 at both incubation ratios were markedly lower by over 10-
fold at 4°C, compared to their corresponding 37°C controls (Figure 4.9A, B). 
This suggests that CFSE entry into MoDCs was by active cellular uptake and 
not by passive diffusion of free CFSE dye that might have leaked out of 
labelled parasites. It also demonstrates active uptake of CFSE-labelled 
Blastocystis during an incubation window within which it was previously 
shown that the labelled parasites still retained normal cell morphology and 
comparable fluorescence intensity to parasites fresh labelled with CFSE. In 
further investigations in which phagocytosis was inhibited, the lack of 
significant MoDC activation suggests that prior ingestion of live Blastocystis 
spp. is required for MoDC activation (Figure 4.9C). 
 
4.3.2.2  Cytokine/Chemokine ELISA  
Besides changes to surface marker phenotypes, immune mediators such as 
cytokines and chemokines secreted by MoDCs are another sign of activation 
and maturation. We set out to identify which of these mediators would be 
secreted by mature and activated MoDCs, which are the main antigen-
presenting cells bridging innate and adaptive arms of immunity. To this end, 
immature MoDCs were cultured with live ST4-WR1 and ST7-B parasites or 
parasite lysate for 24hr before culture supernatant was collected and screened 
for MoDC activation-associated cytokines and chemokines like IL-8, IL-12 
and TNF-α. We observed significantly higher MoDC production of TNF-α 
and not of IL-8 or IL-12, when compared to baseline levels from the negative 
control of MoDCs in complete media and unexposed to Blastocystis (Figure 
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4.10, 4.11, 4.12). We also observed that only live ST7-B parasites were able to 
induce such levels of TNF-α secretion from MoDCs.   
 
4.3.3  Effects on CD4
+
 T cell proliferation 
Dendritic cells are the most efficient antigen presenting cells and by 
presenting antigens to naïve CD4
+
 T lymphocyte populations in secondary 
lymphoid organs, they drive activation and proliferation of these immune cell 
populations, priming them towards effector functions at sites of infection. 
Upon observing MoDC activation and maturation after exposure to 
Blastocystis, we proceeded to study the capabilities of MoDCs in CD4
+
 T cell 
proliferation.  
 
Interestingly, we did not observed the expected proliferation of CD4
+
 T cells 
by parasite-conditioned MoDCs. Instead, we observed an almost 10-fold 
inhibition in the T-lymphocyte activating capabilities of parasite-conditioned 
MoDCs, reflected in the significantly lower degrees of T cell proliferation 
(Figure 4.13A). In addition, inclusion of a pro-inflammatory immunogen like 
LPS in the MLR co-cultures failed to induce any increase in CD4
+
 T cell 
proliferation. The presence of LPS in MLR co-cultures is expected to boost T-
lymphocyte proliferation, as reflected in the positive control (Figure 4.13A). 
 
We also employed a different approach to assess CD4
+
 T cell proliferation as a 





 T cell proliferation with or without Blastocystis. 
We observed a similar trend of inhibition in PHA-induced CD4
+
 T cell 






















Fig 4.1. Analyses of permeability changes to Caco-2 monolayers after 
Blastocystis exposure. (A) TEER measurements of Caco-2 monolayers before 
and after exposure to live ST7-B parasites. Bar chart of mean TEER and error 
bars represent mean standard errors of the means. Data shows dose-dependent 
increase in monolayer permeability by live ST7-B parasites. Exposure to 
10×10
6
 parasites is equivalent to an exposure ratio of 1 Caco-2 cell to 10 
parasites. (B) FITC-dextran flux across Caco-2 monolayers after exposure to 
ST7-B lysate content equivalent to an exposure ratio of 1 Caco-2 cell to 10 
parasites. Bar chart of mean fluorescence intensity and error bars represent 
mean standard errors of the means. Increased fluorescence in basolateral 
media demonstrates increased FITC-dextran flux across monolayers and 
increased permeability after exposure to ST7-B lysate. * p<0.05; ** p<0.01.  
p-values generated from comparisons with negative control (media). 3 




















Fig 4.2. TEER analysis of permeability changes to Caco-2 monolayers after 
exposure to large or small Blastocystis. Caco-2 monolayers were exposed to 
different exposure ratios of either live Blastocystis parasites or parasite lysate, 
after which permeability was assessed by TEER measurement. Exposure ratios 
are in terms of Caco-2 cells to live Blastocystis parasites or parasite lysate, 
with lysate amount quantified by protein content from fixed numbers of 
parasites. ** p<0.01. p-values generated from comparisons with negative 
control (media) or with positive control (cytochalasin-D). 3 independent 

















Fig 4.3. Diagrammatic representations of experimental set-ups employed for 
MoDC experiments. Indirect incubations involved spatial separation of live 
parasites from MoDCs by a 0.4µm pore-size transwell filter insert or by a 
confluent Caco-2 monolayer grown in a 3µm transwell insert. MoDCs were 
also directly co-cultured with live parasites. 
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Fig 4.4. Flow cytometric analysis of MoDC activation and maturation after 
Blastocystis exposure. (A) Representative flow cytometry histograms showing 
ST7 B isolate-induced up-regulation in activation markers CD80 and CD83. 
Note the significant increase in CD80 up-regulation in live parasite-LPS co-
culture with MoDCs. Numerical data represent mean fluorescence intensities. 
(B) Pooled flow cytometry analysis of CD80 and CD83 expression on MoDCs 
after exposure to different conditions in direct or indirect configurations. 
CD80 and CD83 up-regulation is observed only for MoDCs directly cultured 
with live ST7-B. Bar chart of mean fold change in fluorescence intensity and 
error bars represent standard errors of the means. *p<0.05. p-values generated 
from comparisons with negative control (complete media). 3 independent 






+ 1µg/ml LPS 
 
Live ST7-B  
 
ST7-B lysate 







































Fig 4.5. Flow cytometric analysis of MoDC maturation after exposure to large 
or small parasites. Pooled flow cytometry analysis of CD83 expression on 
MoDCs after exposure to parasites separated by size using centrifugation 
methodology described in Chapter 2. Only ST7-B showed significant CD83 
up-regulation. Both large and small parasites induced similar degrees of CD83 
up-regulation. Bar chart of mean fluorescence intensities and error bars 
represent standard errors of the means. *p<0.05. p-values generated from 
comparisons with negative control (complete media). 3 independent 

















Fig 4.6. Flow cytometric analysis of MoDC activation after exposure to live 
parasites or parasite lysate. Pooled flow cytometry analysis of CD80 
expression on MoDCs after exposure to live parasites or parasite lysate. Only 
live parasites induced significant CD80 up-regulation. Co-culture of live ST7-
B parasites with LPS showed augmentation in up-regulation in CD80. Bar 
chart of mean fluorescence intensities and error bars represent standard errors 
of the means. **p<0.01. p-values generated from comparisons with negative 
control (complete media). + p<0.01 against 1µg/ml LPS positive control. 3 























Fig 4.7. Flow cytometric analysis of change in CD80+, CD83+ activated 
mature MoDCs. (A) Representative scatter plots showing increase in CD80+, 
CD83+ activated mature MoDCs after exposure to live ST7-B and 
augmentation of percentage of CD80+, CD83+ activated mature MoDCs in 
live ST7-B+LPS co-culture. MoDCs were gated by positive CD11c labelling. 
Values in scatter plots are percentages making up 100% of CD11c+ cells. (B) 
Pooled data from 3 independent experiments. Bar chart is of mean percentages 
of CD80+, CD83+ activated mature MoDCs from a population of CD11c+ 
cells. Error bars are of SEM calculated from 3 independent experiments. Live 
ST7-B increases the percentage of activated, mature MoDCs and augments 
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Fig 4.8. Confocal microscopy of MoDCs in direct contact with Blastocystis. 
(A) Representative confocal micrographs at 60× magnification. Merged 
composite images show localization of CFSE-labelled parasites within cell 
periphery of MoDCs labeled with AF647 against MHC(I) and Hoechst nuclear 
stain. (B) Z-stack analysis of confocal micrographs at 60× magnification. 
Magnified inset (red boxes) shows phagocytosis of CFSE-labeled parasites or 






























Fig 4.9. Flow cytometric analysis of uptake of live CFSE-labelled Blastocystis 
by MoDCs and inhibition of phagocytosis in MoDCs. (A) Representative 
histograms of CFSE fluorescence intensity in MoDCs exposed to CFSE-
labelled parasites at either 4°C or 37°C. MoDCs were distinguished from 
CFSE-labelled parasites by PE-conjugated HLA-ABC gating. Markedly lower 
CFSE fluorescence intensities were recorded for MoDCs exposed to labelled 
parasites at 4°C. (B) Pooled data from 3 independent experiments, showing 
mean fluorescence intensities (MFI). Error bars are of SEM. (C) Pooled flow 
cytometry analysis of CD80 expression on MoDCs after exposure to live 
parasites. Prior to exposure to live parasites, MoDCs were conditioned in 
complete media with or without cytochalasin-D for 1 hour at 37◦C. ST7-B-
mediated activation was no longer observed in MoDCs after inhibition of 
phagocytosis by cytochalasin-D. Error bars are of SEM (n=3). *p<0.05. p-
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Fig 4.10. TNF-α ELISA of MoDC culture supernatant after exposure to live 
parasites or parasite lysate. Bar chart of mean cytokine levels (pg/ml) and 
error bars represent standard errors of the means. **p<0.01. p-values 
generated from comparisons with negative control (complete media). 3 






Fig 4.11. IL-12 ELISA of MoDC culture supernatant after exposure to live 
parasites, in the presence or absence of LPS. Bar chart of mean cytokine levels 
(pg/ml) and error bars represent standard errors of the means. No significant 
induction of IL-12 production observed from MoDCs after Blastocystis 
exposure. No significant difference in LPS-mediated IL-12 production in the 
presence of Blastocystis. **p<0.01. p-values generated from comparisons with 









Fig 4.12. IL-8 ELISA of MoDC culture supernatant after exposure to live 
parasites. Bar chart of mean chemokine levels (pg/ml) and error bars represent 
standard errors of the means. Slight but non-significant induction of IL-8 
production observed from MoDCs after exposure to live ST7-B. *p<0.05. p-
values generated from comparisons with negative control (complete media). 3 























Fig 4.13. Analysis of CD4
+
 T cell proliferation after Blastocystis exposure by 
tritium-thymidine incorporation assay. (A) Bar chart of mean radiation counts 
(cpm) and error bars represent standard errors of the means. Significant 
reduction in T-lymphocyte proliferation compared to background levels from 
MLR basal control. Significant lack of LPS-augmented T-lymphocyte 
proliferation in Blastocystis-conditioned MLRs. (B) Bar chart of mean 
radiation counts (cpm) and error bars represent standard errors of the means. 
Dose-dependent Blastocystis-mediated inhibition in PHA-induced T-





/ml. *p<0.05; **p<0.01. p-values generated from 
comparisons with negative control (MLR basal control) or positive controls of 






In the previous chapter, we described and discussed data from experiments to 
investigate effects of Blastocystis on elements of immunosurveillance that 
constitute upstream components of inate immunity. We demonstrated that 
Blastocystis in isolation did not activate TLRs leading to NF-κB activation. 
Interestingly, we observed that Blastocystis exhibited a range of modulatory 
effects on TLR signalling by specific pathogen-associated molecular ligands. 
Implications on immunosurveillance in the intestinal mucosal 
microenvironment and the regulation and possible dysregulation of intestinal 
immune homeostasis were discussed.  
 
The chief focus of this chapter is in investigating interactions between 
Blastocystis spp. and MoDCs, in the context of epithelial barrier function of 
the colonic epithelium. Firstly, through TEER and FITC-dextran flux 
measurements, we confirmed earlier findings of Blastocystis spp.-mediated 
epithelial barrier permeability increase
106
, that ST7-B lysate consistently 
induce increase in epithelial permeability increase of Caco-2 monolayers. Our 
findings also complement precedent data in literature, in that we also 
compared effects of live parasites of different isolates and subtypes on 
epithelial permeability. Along with ST7-B lysate, live ST7-B parasites also 
induce significant increase in epithelial permeability of Caco-2 monolayers. 
Expectedly, live ST4-WR1 lysate did not induce significant increase in 






Adding to this finding, we also observe the lack of increase in epithelial 
permeability by live ST4-WR1 parasites at the same exposure ratio as ST7-B, 
based on cell numbers. A recent study showed that ST7-B lysate exhibited a 
positive dose-dependent effect on epithelial permeability increase of Caco-2 
monolayers
106
. The same study also exposed Caco-2 monolayers to the same 
doses of ST4-WR1 lysate and found that there was no significant TEER drop 
even in Caco-2 monolayers exposed to the highest ST4-WR1 parasite load 
used, suggesting that ST4-WR1 may be truly unable to impair barrier function 
of colonic epithelial monolayers and less likely that any previous lack of 
observations of increase in epithelial permeability was due to too mild an 
exposure to ST4-WR1. While much has been done towards characterising 
global prevalence of Blastocystis, no study in literature to date has accurately 
determined a reasonable estimated parasite load in an infected human 
individual. A recent review stated that there is a possible association between 
severity of gastrointestinal symptoms and parasite density, more specifically 
that the presence of greater than five parasites per high-power field (×400) for 
wet mounts or under oil immersion (×1000) in permanent-stained smears is 
often linked to acute presentations of gastrointestinal symptoms
25
. However, 
how this relationship translates to broader parameters like infectivity ratios 
remains unclear.  
 
Blastocystis spp. is generally observed to be a non-invasive unicellular 
parasite that colonizes the luminal side of the colonic epithelium. Previously 
observed Blastocystis-mediated increase in epithelial permeability had been 
attributed to the induction of enterocyte apoptosis
106





 and disruption of tight junction proteins
104
. All these effects 
may contribute towards impairment in barrier function. In severe cases of 
barrier compromise, sloughing of mucosa has been observed in Blastocystis-
infected rats
81
. Irritable bowel syndrome (IBS), to which Blastocystis spp. is 
increasingly associated with, had also been characterized by an increase in 
epithelial permeability coupled with disruptions to tight junction proteins
137
. 
Taken together with previously reported ST7-B-mediated increase in 
permeability and our own observations, Blastocystis-induced damage to the 
colonic epithelium and severe barrier function compromise may provide 
immune-sensing cellular elements of host immunity, such as DCs, direct 
access and contact with Blastocystis cells, allowing Blastocystis-mediated DC 
activation and effecting host immunity towards a response. In addition, as 
previously discussed in Chapter 3, Blastocystis-mediated intestinal epithelial 
barrier function compromise may provide TLRs localized beneath the apical 
surface of the intestinal epithelium access to luminal pathogen-derived 
ligands. For instance, TLR-5 is the predominant receptor for bacterial 
flagellin
116
, mainly expressed in the basolateral colon
115
. This implicates an 
accessory role in Blastocystis spp. towards bacterial induction of intestinal 
inflammation, which contributes to an emerging picture of the direct and 
indirect participation of Blastocystis spp. in the disruption of intestinal 
homeostasis. 
 
Dendritic cells play a key role in immune surveillance in mucosal tissue. In the 
presence of pathogen-associated factors, they undergo activation and 
maturation, draining into secondary lymphoid organs and transitioning into the 
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. Several recent 
studies have begun investigating interactions between DCs and protistan 
parasites. Entamoeba histolytica has been found to activate and mature DCs 
towards T-helper 1 (Th1) immune responses
76
. Giardia lamblia was also 
observed to activate DCs but modulates DC function with enhanced IL-10 
secretion in the presence of TLR ligands
77
. To date, no study has been 
conducted to study interactions between DCs and Blastocystis spp. In this 
study, we present first evidence of Blastocystis-induced activation of dendritic 
cells, a crucial immunosensing component of host immunity that bridges both 
innate and adaptive arms of the immune system. We report significant up-
regulation of activation and maturation markers CD80 and CD83, indicating 
MoDC activation and maturation, only by direct contact with live Blastocystis 
spp. ST7-B. We also observe uptake of fluorophore-labelled Blastocystis spp. 
by MoDCs, presenting a possible mechanism that leads to Blastocystis-
induced MoDC activation.  
 
In the temperature-dependent verification experiments of active Blastocystis 
spp. uptake by MoDCs, the low fluorescence values of MoDCs exposed to 
labelled ST4-WR1 strongly suggest that CFSE was mostly retained within the 
parasites and that there was only a very small amount of free CFSE in the 
culture media that could have diffused into the MoDCs. The markedly higher 
CFSE fluorescence in MoDCs exposed to labelled ST7-B at 4°C also implies 
that CFSE might have leaked out of ST7-B parasites more readily than ST4-
WR1, resulting in a greater degree of passive and non-specific diffusion of 
CFSE into MoDCs.   
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In view of findings from confocal microscopy and flow cytometric analyses, 
we demonstrate active uptake by MoDCs of CFSE-labelled Blastocystis 
during an incubation window of 4 hours, within which the parasites still 
retained normal cell morphology and comparable fluorescence intensity to 
parasites freshly labelled with CFSE. It is to be noted that these findings 
constitute first observations of Blastocystis spp., an extracellular enteric 
parasite, subjected to phagocytosis by a host immune cell. We also present 
first evidence of a direct effect of Blastocystis spp. on a class of human 
immune cell and provides a nascent understanding of mechanistic processes 
behind the activation of an immune response against Blastocystis spp. 
 
To date, there are no findings in literature that report the ingestion of 
Blastocystis spp. by a host cell. Latest findings in the context of cell-to-cell 
interactions between Blastocystis spp. and host cells report that galactose 
effectively decreased adhesion of ST7 Blastocystis spp. on colonic epithelial 
cells
104
. Earlier findings in studies aimed at understanding the cellular 
structure of Blastocystis spp. identified several surface coat carbohydrates, 
such as alpha-D-mannose, alpha-D-glucose, N-acetyl-alpha-D-glucosamine, 
alpha-L-fucose, chitin and sialic acid, using lectin probes
139
.   
 
Various C-type lectin receptors (CLRs) have been identified on dendritic cells 
that are involved in the recognition of a wide range of carbohydrate moieties 
on antigens
140
. Some of these receptors, such as Dectin-1, DC-SIGN and 
mannose receptors are increasingly being viewed as being more than just 
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scavenger receptors and they may possess regulatory roles in cell signalling or 
function as cell adhesion receptors
140
. Several C-type lectins expressed by 
DCs have specificity for mannose-containing carbohydrates, depending on 
unique branching and positioning of the mannose residues on the antigen 
structure of the pathogen
140
. Mannose receptors are also known to be specific 




Interactions between Blastocystis spp. and CLRs on host cells have not been 
studied, despite earlier identification of several carbohydrate components in 
the outer coat of Blastocystis spp. In addition, CLRs constitute a large family 
of pathogen recognition receptors expressed by professional antigen-sensing 
and antigen-presenting cells, such as dendritic cells, in immunosurveillance 
along sites such as the gut mucosa. Taking these together, we speculate that 
CLRs may be involved in adhesion of Blastocystis spp. to dendritic cells and 
facilitate the uptake of the parasite into dendritic cells. 
 
Besides direct access between MoDCs and parasites mediated by extensive 
epithelial damage, MoDCs have been observed to extend dendritic processes 
across the intestinal epithelium to sample luminal contents. A population of 
murine CD103
+
 DCs within the epithelial layer was recently visualised 
sampling bacteria directly from the intestinal lumen via dendrites extended 
between epithelial cells
142
. The same study showed that this population of DCs 
were able to ingest both invasive and non-invasive bacteria strains with similar 
efficiency
86,142
. In vitro studies over the last decade, in human MoDCs were 
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incubated facing the basolateral membrane of Caco-2 monolayers, a human 
colonic epithelial cell line. These MoDCs were observed to translocate across 
the epithelial barrier upon apical incubation of both pathogenic and non-
pathogenic bacterial strains
138,143
. However, similar functions of colonic DCs 
have not been documented in human tissue samples. In addition, colonic DCs 
are rarely found in the epithelial layer of naive animals
144,145
. Phagocytic 
uptake of luminal contents by DCs in the colon has rarely been observed, and 
until recently may even be considered a nonevent
144
. In a mouse model of 
Trichuris muris infection, epithelia-associated colonic DCs were observed to 
have short dendrite projections that extended between epithelial cells
144
. The 
same study also observed that postinfection, several DCs had breached the 
basement membrane and were in direct contact with the epithelium. However, 
the authors suggest that based on their data, the formation of transepithelial 
dendrites is associated with a postinfection event and too rare to be observed 
in naive mice
144
. In the context of a Blastocystis infection, it has not been 
tested if MoDC phagocytosis of Blastocystis or parasite debris may occur 
across an epithelial barrier. We propose that future studies into host-pathogen 
interactions between MoDCs and Blastocystis include experiments that 
investigate the possibility of this means of luminal sampling and capture of 
Blastocystis antigens.  
 
Apart from DC activation, we also report significant TNF-α secretion by DCs 
post-exposure to Blastocystis, Previous studies were mostly focused on 
analyses of expression levels and serological quantities
146–148
. This is the first 
report of a cellular source of significant TNF-α secretion after exposure to 
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Blastocystis spp. Apart from being a major pro-inflammatory cytokine, TNF-α 
has been found to induce increase in epithelial permeability through NF-κB-
dependent down-regulation of ZO-1 protein expression and alteration in 
junctional localization
149
. Taken together, this suggests that Blastocystis spp. 
mediates increase in epithelial permeability and barrier function compromise 
by both directly affecting epithelial architecture, or indirectly via host-derived 
factors that contribute to the same effect of barrier compromise. 
 
As highlighted in Chapter 3, we recently reported that Blastocystis spp. 
mediates an augmented response to LPS by THP1 monocytes in the presence 
of ST7-B
150
, leading to a greater degree of NF-κB activation and suggesting a 
heightened responsiveness of host cells to LPS via its traditional receptor 
TLR-4. Downstream implications of this increased sensitivity to LPS were 
also discussed in Chapter 3. Interestingly, when we investigated possible 
effects of Blastocystis on MoDC response to known immunogens like LPS, we 
observed heightened MoDC activation via significantly higher levels of CD80 
up-regulation than in MoDCs pulsed with LPS alone. Responsiveness to LPS 
has also been reported to be increased in colonic epithelial cells in the 
presence of TNF-α114. This presents yet another effect of exposure to 
increased levels of TNF-α, that it renders the colonic epithelium more 
sensitive to LPS and possibly lowers the threshold of the onset of increased 
colonic mucosal inflammation. Taken together with the increased 
responsiveness to LPS in host cells via TLR-4, markedly higher MoDC 
activation by Blastocystis in the presence of LPS and TNF-α production by 
Blastocystis-activated MoDCs, we present an emerging picture of the possible 
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multi-pronged role of Blastocystis in the disruption of colonic immune 
homeostasis and the exacerbation to pathological levels of inflammation along 
the colonic epithelial microenvironment.  
 
With barrier function of intestinal epithelium compromised, depending on the 
extent of damage to the colonic epithelia, parasite factors from lysed parasites 
and/or live parasites cross the compromised epithelial barrier into the lamina 
propria and further submucosal levels. Isolated reports have alluded to the 
invasive potential of Blastocystis
151–153
, though it has been suggested that it is 
still inconclusive whether Blastocystis can truly invade across the intestinal 
epithelium and induce further pathologies at sites away from the colonic 
microenvironment, as the pre-existing context of these reports include a co-
infection with Entamoeba histolytica and an invasive adenocarcinoma
25
. 
Regardless of the true invasive potential of this parasite and taking together 
plausible modes of parasite lysis previously discussed in Chapter 3, we 
hypothesize that given the marked increase in permeability of the colonic 
epithelium by Blastocystis, both secreted parasite factors and cellular 
components released due to parasite cell lysis may cross the epithelium and 
drain into secondary lymphoid organs proximally located to the gut, such as 
the mesenteric lymph nodes. Transported secreted parasite factors and cellular 
components from lysis may then condition naïve CD4
+
 T cell populations at 




The mixed lymphocyte reaction (MLR) is a functional assay that assesses the 
activation and proliferation of T lymphocytes and is a robust in vitro model for 
the mounting of a primary adaptive immune response. We used this assay to 
assess CD4
+
 T cell proliferation in the presence of Blastocystis and made the 
unexpected observation that although MoDCs were previously found to be 
activated and matured after exposure to Blastocystis, Blastocystis-conditioned 
MoDCs did not induce levels of T cell proliferation comparable even to that of 
background levels in the Blastocystis-free MLR setup. This inhibition in 
proliferation is unlikely to be associated with MoDCs as a second approach to 
induce CD4
+
 T cell proliferation without the presentation of alloantigens from 




 T cell proliferation has been documented in studies on 







, and on the bacterial pathogen Chlamydia 
pneumonia
157
. Mechanisms of inhibition from these studies include G1 cell 
cycle arrest associated with up-regulation of p27
kip1
, a cyclin-dependent kinase 
inhibitor
154
, down-regulation of IL-2Rα expression in human peripheral T 
lymphocytes
155
 and the activation of apoptotic and pyroptotic cellular death 
pathways in activated T cells
157
. We hypothesize that the observed suppression 
in activation of naïve T lymphocyte populations by Blastocystis may be 
another means of modulating host immunity for successful colonization of the 
intestinal epithelium; and that future studies should focus on characterising 
mechanism behind the inhibition of the induction of host adaptive immune 
responses by Blastocystis. A better understanding of these effects may also 
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help explain the non-gastrointestinal allergy-related cutaneous symptoms, 
previously outlined in Chapter 1, that infrequently manifest along Blastocystis 
infections, as such immunopathologies are driven by dysregulated elements of 
the adaptive immune system, such as specific activation of Th2 T cell clones, 
production of specific cytokines that drive antibody class switching to the IgE 
class and generation of autoantibodies that target IgE-receptor
158
. Increase in 
mast cell and mononuclear cell numbers in skin biopsies and increase in 
numbers of circulating eosinophils may serve to confirm accompanying 




In conclusion, we report first findings of interactions between DCs and 
Blastocystis spp. and hypothesize that DCs play an integral role in the 
pathogenesis of this parasite, through increased inflammation and the 
disruption of immune homeostasis in the colonic microenvironment. Future 
studies should focus on more directed investigation to elucidate exact 
mechanisms linking DC activation, TNF-α secretion and downstream effects 
on colonic epithelial cells in the presence in TNF-α. This information would 
contribute towards a better understanding of the pathogenesis of Blastocystis 



















5.1 GENERAL DISCUSSION 
Despite being first described over a century ago by Alexieff and Brumpt
159
, 
many aspects of Blastocystis spp. biology and its role in host-pathogen 
interactions remain poorly studied. Several factors contribute to the inherent 
difficulty in conducting conclusive studies towards advancing understanding 
of the role and effects of Blastocystis in acute and chronic infections, and as a 
member of the colonic microbiota in the human host. 
 
As discussed in Chapter 2, Blastocystis exhibits high genetic heterogeneity 
and numerous isolates of Blastocystis spp. from mammalian and avian hosts 
had been classified into 17 different subtypes, of which 9 had been 
documented in human hosts
6
. Among these 9 subtypes, subtypes 1 to 4, as 
well as 7 are clinically relevant to humans. Several studies in literature have 
compared isolates from different subtypes in attempts to establish and 
compare pathogenicities of the different subtypes, as has been the main 
strategy of experiments discussed in this thesis. Recent findings have reported 
clear differences in effects on host cells by different Blastocystis subtypes, in 
levels of adhesion to host cells and subsequent disruption of tight junction 
proteins and epithelial barrier function
104
, induction of apoptosis in host 
enterocytes
106
, and in susceptibility to and modulation of the host nitric oxide 
response
70




While these studies contribute to the increasingly accepted hypothesis that 
Blastocystis pathogenicity varies among subtypes, more subtypes should be 
examined and compared with regard to effects of host tissue. Most certainly, 
more epidemiologically prevalent and clinically prolific subtypes like 1-3 
should be subjected to direct comparative experiments in vitro to provide a 
better characterisation of the pathogenicity of subtypes that are most 
commonly encountered in patients. However, the breadth of such comparative 
studies would depend on the availability of axenic cultures of isolates 
classified under these subtypes. To this end, more focus may be centred upon 
axenisation of more isolates from both symptomatic and asymptomatic human 
hosts to build upon a library of axenic isolates from which subtypes observed 
in humans may be adequately represented. 
 
In addition, the need for more axenic isolates to represent each isolate is 
further underscored by recently observed intra-subtype variation, both through 
genetic and cladistics analysis
134
, and in vitro observations in direct cell 
culture experiments and differential effects on host cells among isolates within 
a single subtype
104
. This reflects an increasing need to include more isolates to 
represent subtypes in comparison studies. In our study, we focused on 
comparing subtypes 4 and 7 through isolates WR1 and B respectively and 
arrived at first characterisations of direct effects of Blastocystis on elements of 
host immunity. Future work should not only focus on more in-depth 
investigations on mechanistic understandings of these previously observed 
effects, but also on the inclusion of more isolates to represent subtypes 4 and 
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7, as well as that of other subtypes, such as 1-3, to enhance the breadth of 
work done so far.  
 
In our study, we noted differences between isolate WR1 of subtype 4 and 
isolate B of subtype 7 in terms of cell size and protein content. Our findings of 
cell size are generally consistent with previously reported findings
95
 and we 
provide first characterisations of differences in intracellular protein levels 
between the two isolates of subtypes 4 and 7. We utilised these findings in 
refining exposure parameters of parasites against host cells towards more 
comparable investigations into effects of both isolates and the subtypes 
represented against host cells, which potentially allude to pathogenicities of 
the isolates and their respective subtypes. We predict that such cellular 
differences will also be present to varying degrees in other isolates not used in 
our study. Thus, similar cellular characterisations should also be carried out 
for these isolates to ensure optimised exposure ratios to host cells, so that 
findings of subsequent comparative in vitro experiments, such as those carried 
out in our study that investigate TLR signalling and DC function, may also be 
comparable. 
 
Besides the need for more axenic isolates for better representation of clinically 
relevant subtypes, a dearth of findings still exist in the context of potential 
virulence factors from the parasites and molecular mediators of 
immunological potential. To date, only 1 study has provided purification and 
function descriptions of a Blastocystis factor
160
. However, findings from that 
122 
 
studies were only limited to functions of the Blastocystis asparagine 
endopeptidase legumain on parasite cellular biology. More recently, in silico 
analysis of the recently sequenced
161
 Blastocystis subtype 7 genome, coupled 
with substrate gel electrophoresis experiments and mass spectrometric 
analysis, had identified two putative secreted cysteine proteases, a cathepsin 
B-like protease and a legumain
162
. As suggested previously, whether these 
secreted proteins act on host cells and disturb gut function has not been 
studied
104
. At the time of this study, revisiting of the purification of the 
surface-localised legumain was not within the scope of the study and no 
purified legumain was available for use as a Blastocystis factor to which host 
cells such as dendritic cells and macrophages may be exposed. Also, the 
previously described putative secreted cysteine proteases have not been 
subjected to direct exposure experiments to host cells to elucidate any possible 
effects of these proteins on host cells, nor has their immunogenicity been 
investigated.    
 
It was recently postulated that Blastocystis ST7 likely uses hydrolases to 
attack host tissues for its nutrient supply as sequences coding for enzymes 
such as fucosidase, hexosaminidase, and b-galactosidase were identified in the 
Blastocystis ST7 predicted secretome, which may degrade host glycoproteins, 
along with cysteine proteases that have been found to have such degrading 
activity
88,161,163
. This hypothesis not only suggests a potential nutrient source 
for Blastocystis, but also outlines possible first steps towards the onset of 
inflammation as the protective mucin layer above the colonic epithelial barrier 





Currently, ongoing work is done to address this previously unexplored aspect 
of interaction between Blastocystis and the host colonic epithelium and early 
findings from exposure experiments with excised mouse large intestinal 
epithelial tissue suggest that live Blastocystis ST7 could be hampered by the 
mucous layer on top of the colonic epithelium (unpublished). It would be 
interesting to explore this aspect of Blastocystis colonisation on the intestinal 
epithelium because if  live parasites are indeed found to be spatially impeded 
by the thick mucus layer, downstream effects of Blastocystis infection on the 
intestinal epithelium would likely involve impairment of the mucous layer 
until Blastocystis has direct access to host tissue, along with secreted parasite 
factors and released cytoplasmic contents from lysed parasites, that diffuse 
through the mucus layer to exert effects on host tissue beneath. In addition, 
animal models used in earlier studies reported pathologies to intestinal mucosa 
and increased inflammation in Blastocystis-infected rats
35,81
. Mucin 
composition of caecal goblet cells has also been found to be changed by 
Blastocystis in infected rat models
35
. The authors of that study suggest that this 
change in mucin composition may alter the mucosal surface charge and affect 
the attachment of Blastocystis to the epithelial barrier
35
. Regardless, whether 
there are significant Blastocystis-mediated changes to the mucus layer by 
degradation of alterations to mucin composition remains an interesting and 
pertinent question to answer for Blastocystis host-pathogen interactions to be 
better understood. Such studies may provide valuable insights into 
mechanisms employed by Blastocystis to establish an infection in the presence 
of the mucus layer. 
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Another element of innate immunity that warrants further investigation into is 
the family of antimicrobial peptides. Members of this family that are 
expressed along mucosal localities include β–defensins and cathelicidins. 
Other enteric parasites, such as Entamoeba histolytica, have been found to 
induce and degrade intestinal cathelicidins and are resistant against their 
antimicrobial activity
124
. Currently, ongoing work by colleagues is focused on 
investigating the susceptibilities of Blastocystis to antimicrobial peptides and 
also on determining whether Blastocystis possesses any modulatory or evasive 
capabilities against host antimicrobial peptide response. Early data suggests 
that Blastocystis induces increase in cathelicidin expression from transformed 
human colonic epithelial cells (unpublished). Increased expression of 
cathelicidin has been coupled to activation of bacterial DNA-mediated TLR9-
ERK signalling in human monocytes and in experimental mouse models of 
colitis
164
. As discussed in Chapter 3, dysregulated TLR signalling leading to 
NF-κB activation may contribute towards the perpetuation of a chronically 
inflamed state of the intestinal epithelium and the onset of IBS and IBD. 
Taken together, Blastocystis effects on cathelicidin expression and function 
and on TLR signalling may work concomitantly towards pathological 
intestinal inflammation.  
 
Animal models of Blastocystis infection have been developed in an increasing 






. More recently, 
the suitability of pigs as another animal model was explored
169,170
. Though 
numerous recent studies involving animal models use the rat as the animal of 
choice, findings from these studies of an immunological nature have been 
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limited, mostly regarding effects on mucosal tissue and general mucosal 
inflammatory states by general screens of cytokine and chemokine levels
35
. 
Later studies involving experimentally infected mice have begun more in-
depth investigations into immunological mechanisms involved in Blastocystis 
infections
82,171
, and this suggests that even though mice do not generally 
harbour Blastocystis, they may still be relevant models to investigate acute 
immunological responses against Blastocystis challenge.   
 
Besides the use of animal models, host-pathogen interactions between 
Blastocystis and host immunity may be explored using in vitro tools. MoDCs 
have been used as an in vitro cellular model for intestinal DCs in several 
studies that investigate pathogenic mechanisms underlying infections of other 
intestinal parasites like Entamoeba histolytica
76,172–174
 and Giardia lamblia
175
. 
Although the use of MoDCs has been instrumental in serving as a model 
platform to elucidate many aspects of the cellular mechanisms underlying the 
initiation of immune responses against intestinal protozoan parasites, MoDCs 
are limited in that they may not accurately mimic the subsets of intestinal DCs 
that reside in the submucosa beneath the intestinal epithelium. Recently, 
intestinal CD103
+
 dendritic cells have been specifically identified as major 
players in innate immune control of Cryptosporidium parvum infection in 
neonatal mice
176
. To date, no studies have been conducted to investigate the 
corresponding intestinal DC subset in the human intestine in the context of a 
parasite infection. Future studies to build on our observations on Blastocystis 
effects on DCs derived from human peripheral blood monocytes should centre 
on how the parasite affects intestinal DC subsets in infection models of the 
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mouse and the rat. This would enhance physiological and spatial relevance of 
these studies to the physiological setting of Blastocystis infection.    
 
Besides intestinal dendritic cell subsets, other immune cell types have been 
identified to play major roles in the maintenance of intestinal immune 







macrophages derived from monocytes recruited from blood to the site of 
infection as described earlier in Chapter 1, as well as the recently-identified 
innate lymphoid cell (ILC) populations that function as regulators of intestinal 









 intestine-resident macrophages lack migratory 
properties in the steady state and instead persist in close physical contact with 
epithelial cells, where they act as avid phagocytes to mediate clearance of 
pathogens and commensal bacteria that traverse the epithelial barrier
177
. ILCs 
are characterized by their differential cytokine expression into group 1, group 
2 and group 3 ILCs, which share functional similarities with the adaptive 
CD4+ Th1, Th2 and Th17 cell populations, respectively
177
. Inclusion of these 
distinct immune cell types, along with DCs, in future immunological 
investigations into Blastocystis infection will greatly enhance the depth of 
these studies and also more fully appreciate the complexity inherent in the 





In conclusion, our data demonstrates that while Blastocystis exhibits a range of 
effects in several aspects of mucosal immunity, such as the modulation of 
ligand-specific TLR activation and MoDC activation and maturation with 
TNF-α production, most of these effects contribute to and streamline towards 
a few outcomes downstream. Firstly, host cells like monocytes and MoDCs 
have consistently shown to be possess increased sensitivity to immunogens 
like LPS after exposure to Blastocystis and secondly, our data suggests that 
ultimately these effects of augmentation, along with MoDC activation and 
maturation by ST7-B alone, may contribute towards driving the host colonic 
epithelial microenvironment towards a heightened or chronic state of 
inflammation, as modelled in Figure 5.1. In working towards a wider-ranging 
and comprehensive understanding of the increasingly complex picture of the 
pathogenicity of Blastocystis spp., future experiments should focus on 
investigations that involve more isolates to represent more subtypes that are 
clinically relevant to humans; and bringing the study of Blastocystis spp.-host 
interactions to the intestinal mucosal context, through direct study of native 
immune cell populations in the intestinal mucosa. Through this work, efforts 
continue to delineate mechanisms that underpin symptoms associated with 
Blastocystis spp. infections and to provide more accurate insights into the 
pathogenesis of this highly prevalent enteric parasite and how it interacts with 
gut mucosa. In turn, this information would provide clinicians with a more 






1. Significantly different intracellular protein content between isolates 
WR1 and B of zoonotic subtypes 4 and 7 respectively was observed. 
ST7-B contains approximately five times more intracellular protein 
content than ST4-WR1 per parasite cell. 
2. We developed and optimised a means of size-based segregation of 
Blastocystis parasites by sequential centrifugation and the labelling of 
live ST4-WR1 and ST7-B parasites with the fluorescent viability dye 
CFSE for use in future direct incubation experiments with MoDCs. 
3. Using the transgenic human monocyte cell line THP1-Blue as a 
reporter line for TLR signalling and NF-κB activation, we observed 
that firstly that both live ST4-WR1 and ST7-B parasites, and parasite 
lysate, failed to induce NF-κB activation via TLR signalling. In 
experiments exposing THP1-Blue cells to parasite lysate, we observed 
that only ST7-B and not ST4-WR1 was able to augment LPS-mediated 
NF-κB activation. A dose-dependent inhibition in ZG-mediated NF-κB 
activation was observed for both ST4-WR1 and ST7-B. 
4. Through TEER measurements, we observed that at the exposure ratio 
of 1 Caco-2 cell to 10 parasites, only ST7-B and not ST4-WR1 was 
able to induce significant permeability increase across Caco-2 
monolayers. However, based on previously documented differences in 
protein content between ST4-WR1 and ST7-B and after adjusting 
exposure ratios to increase the degree of ST4-WR1 challenge to Caco-
2 to match that of ST7-B by protein content, we observed similar 
permeability increases by ST4-WR1 to that observed by ST7-B. 
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Similar observations were made when Caco-2 was challenged by 
parasite lysate at similar exposure ratios. 
 
5. Through analysis of CD80 and CD83 surface marker expression levels 
by flow cytometry, we observed significant activation and maturation 
only in MoDCs that were in direct contact with live S7-B parasites. 
Upon challenge of MoDCs with small or large ST4-WR1 and ST7-B 
parasites, only small and large ST7-B induced significant maturation in 
MoDCs. In co-culture experiments of MoDCs together with parasites 
and LPS, we observed heightened activation in MoDCs exposed to live 
ST7-B parasites and LPS. We did not observe the same augmentation 
with ST7-B lysate. Using confocal microscopy and flow cytometry, we 
present for the first time evidence that phagocytosis of Blastocystis 
spp. by MoDCs is coupled with MoDC activation. We also observed 
significant TNF-α secretion only from MoDCs directly exposed to live 
ST7-B parasites and not parasite lysate or ST4-WR1. 
 
6. Lastly, we observed ST7-B-mediated inhibition in CD4+ T lymphocyte 
proliferation both in MLR assay with MoDCs pre-incubated with ST7-
B, and in MoDC-free PHA-induced CD4
+





















Fig 5.1. Model illustrating possible pathogenic and immune evasive mechanisms of 
Blastocystis in driving increased inflammation in the intestinal mucosa. Blastocystis 
induces significant transepithelial permeability increase which permits infiltration of 
luminal contents across the epithelial barrier. Small parasites, released intracellular 
contents from lysed parasites and bacterial components cross the intestinal epithelium 
and contact TLRs and DCs. Parasite lysate mediates increased sensitivity to LPS, 
leading to increased NF-κB activation in epithelial cells. Infiltration of bacterial 
components like LPS and flagellin that are usually blocked by an intact epithelial 
barrier in the steady state binds to specific TLRs like TLR-4, -5 and initiates 
inflammatory responses. DCs that come in direct contact with small parasites that 
pass through the ‘leaky’ epithelial barrier undergo activation and maturation, 
producing the inflammatory cytokine TNF-α, contributing to the mucosal 
inflammatory condition. However, DCs that are conditioned by parasite lysate 
diffused through the epithelial barrier are incapable of inducing CD4+ T lymphocyte 
activation and proliferation in the lymph nodes and secondary lymphoid tissues to 
which the DCs migrate to after exposure to Blastocystis. This presents a possible 
immune evasive mechanism by Blastocystis against downstream adaptive immune 
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